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DEDICATION

“All endeavor calls for the ability to tramp the last mile, shape the last
plan, endure the last hours toil. The fight to the finish spirit is the one
characteristic we must possess if we are to face the future as finishers.”
Henry David Thoreau
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CHAPTER 1: THE STRUCTURE, FUNCTION AND REGENERATION OF BONE
Background
Orthopaedic surgery is a field of healthcare concerned with the diagnosis and treatment
of disorders of the musculoskeletal system resulting from trauma, congenital abnormalities,
tissue degeneration, or other pathology. These disorders may effect any structural component of
the musculoskeletal system, including cartilage, tendon, ligaments, muscle and bone.
Frequently, injury or pathology affecting these structural components result in extreme
dysfunction, pain and an overall reduction in the patient’s quality of life. The societal impact of
musculoskeletal disorders is significant both from a financial and social perspective.

It is

estimated that more than one in four Americans have musculoskeletal pathology or injury
requiring direct medical attention, which is associated with the expenditure of $849 Billion in
indirect costs annually (www.boneandjointburden.org). Musculoskeletal injuries and disorders
account for nearly one third of work days missed by employees.
Owing to the significant impact of musculoskeletal disorders, continuous research and
development work is being performed by scientists and physicians to enhance patient outcomes
associated with orthopaedic surgical procedures. One of the main methods of improving patient
outcomes of surgical procedures is to enhance the rate of healing of the tissue being repaired. As
the primary structural support of the body, bone has received a significant amount of attention in
terms of research aimed at improving healing and regeneration of this important tissue. Most
modern research in the area of bone healing centers on the use of tissue engineering techniques,
including the use of growth factors, multi-potent cells and scaffolds.

Research into novel

scaffold constructs for structural bone tissue engineering has lagged behind the considerable
advancements made in growth factor and stem cells research.
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While numerous materials have been developed to support new bone growth, the vast
majority of these constructs lack the static mechanical properties to support in vivo
biomechanical loading.

Non-resorbable materials, such as porous metals, possess adequate

compressive strength, but their permanence in vivo represents a challenge to surgeons
performing revision surgeries. Device permanence also increases the patients risk for late-onset
infection.

Ceramic materials, such as sintered calcium phosphates, are attractive from the

standpoint of biocompatibility, favorable surface chemistry and porosity. The brittle behavior of
these materials is concerning in the setting of structural bone grafting, especially if there is a
bending or torsional component to biomechanical loading in the desired anatomic location.
Resorbable polymers, especially those based on lactic and glycolic acid are attractive candidate
materials. The predictable and labile degradation profile and nearly four decades of in vivo use
are desirable characteristics. However, concerns persist regarding both the initial mechanical
properties and loss of mechanical strength as a function of construct degradation. This concern
is especially warranted considering the relatively poor mechanical behavior of resorbable
polymer constructs with a porous morphology.
A considerable amount of new research is now focused on reinforcing resorbable
polymer matrices with nanostructured filler materials, such as hydroxyapatite, -tricalcium
phosphate and phosphate glasses. The addition of these filler materials has been associated with
improvements in in vitro osteoblast response, due to their biologic activity. However, only
modest gains in mechanical strength have been reported with these filler particles in lactic and
glycolic acid-based polymer matrices. The lack of significant improvements in reinforcement
have been attribute to the inability to adequately disperse the ceramic particulate in the polymer
matrix. Additionally, it is hypothesized that the poor interaction between polymer chains and the
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ceramic materials does not allow for the effective restriction of polymer chain mobility, which is
necessary for significant improvements in mechanical strength.
A promising new method for synthesizing porous, resorbable polymer nanocomposite
materials has been developed (Baker et al., 2008; Baker et al., 2011). This method shows
promise in terms of the rapid synthesis of nanocomposites suitable for in vivo load-bearing bone
graft substitute applications.

The method consists of dispersing organically-modified

Montmorillonite clays (nanoclay) in a matrix of poly(D-lactide) (PDLA) using supercritical
carbon dioxide (scCO2) processing. In addition to effectively dispersing the nanoclay throughout
the PDLA matrix, scCO2 processing simultaneously imparts an interconnected porous
morphology to the material. The porous morphology is of the resulting nanocomposite construct
is similar that of human cancellous bone. Resulting compressive mechanical properties are
similar to normal human cortico-cancellous bone. In vitro and in vivo analyses illustrate the
ability of the scCO2-processed resorbable polymer nanocomposites to support bone formation,
thus making it an ideal candidate for bone graft substitute applications.
Structure of Human Bone
In order to effectively develop a material to replace a tissue, a knowledge about the
structure and biology of the tissue is required. Bone is a true composite material comprised of a
predominantly organic matrix, reinforced by inorganic consituents. The organic matrix of bone
consists primarily of Type I collagen (90%), with additional collagens, non-collagenous
extracellular matrix proteins, lipids, growth factors and cytokines.

This organic matrix is

reinforced by inorganic substances, principally hydroxyapatite. Hydroxyapatite is a calcium
phosphate-based mineral (Ca10(PO4)6(OH)2), which is present within the collagenous organic
matrix as plate-like crystals approximately 20-80 nm in length and 2-5 nm in thickness.
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Numerous elemental substitutions are possible within hydroxyapatite crystals, including Mg2+,
Sr2+, Na+ and K+ substituting for calcium. Phosphate groups can be replaced by carbonate
groups, or hydrogenated phosphates, while the hydroxyl group can also become carbonated, or
fluorinated. These substitutions depend on age, anatomic location and the presence of disease
states and tend to have a large effect on solubility, rather than structural properties (Bolstrom et
al., 2000)
On a macroscopic scale, human long bones (i.e. femur, humerus, tibia, etc.) are
comprised of a dense outer shell called cortical bone. The dense cortical bone transitions
abruptly to a porous morphology referred to as cancellous bone. Cortical bone is comprised of
individual functional units called osteons, which are oriented longitudinally in most long bones,
as shown in Figure 1. Osteons are composed of rings of cortical bone, referred to as lamellae,
which surround the Haversian canal. Bone’s neurovascular supply runs through these canals
after being fed from the outer sheath of tissue known as the periosteum. Osteons are bonded to
one another at the periphery by the cement line, which is a region rich in glycosaminoglycans.
Volkmann’s canals run in a pseudo-tangential path and act as the connection between individual
osteons and also serve as connections between the osteon and periosteum.
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Figure 1. Illustration of the hierarchical structure of cortical and cancellous bone. (Image
taken from Haeys WC: Biomechanics of cortical and trabecular bone: Implications for
assessment of fracture risk, in Basic Orthopaedic Biomechanics. New York, NY, Raven Press,
1991, pp 93-142.)
The porous core of the long bone is comprised of cancellous bone, which is extremely
porous in morphology, but rigid enough to withstand biomechanical loading.

On an

ultrastructural and compositional level, cancellous bone is identical to that of cortical bone. The
main difference is the density of the tissue. As previously mentioned, cortical bone is comprised
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of densely packed osteons running in a longitudinal direction, parallel to the primary direction of
biomechanical loading. Cancellous bone is comprised of a network of interconnected trabecular
struts, as shown in Figure 2, and does not contain the same Haversian system that cortical bone
does. Depending on the anatomic location and even the location within the long bone, the
morphology of the functional units (trabeculae) of cancellous bone vary from being rod-like to
plate-like. Similar to cortical bone, trabeculae are composed of lamellae, which are oriented in a
longitudinal fashion, rather than concentrically.

Figure 2. Interconnected porous morphology of human cancellous bone. Image taken from
www.sciencephoto.com.
Cell Biology of Bone
Functionally, bone hosts three distinct cell types, which include osteoblasts, osteocytes
and osteoclasts. Bone is the only tissue that contains two specific cell types that are responsible
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for tissue formation and tissue destruction. Tissue formation and destruction is a normal process
within human bone and relies on the coupling between osteoblast and osteoclast function.
Osteoclasts are the cell type responsible for resorption of bone and are descended from marrowderived hematopoietic progenitor cells that additionally give rise to a monocytic lineage. Mature
osteoclasts reside within the structure of bone in small cavities called Howships lacunae and
express tartrate-resistant acid phosphatase (TRAP). In order to resorb bone, osteoclasts attach to
the proposed site of resorption through integrin binding. Once attached, osteoclasts utilize a
carbonic anhydrase system to produce pH-lowering hydrogen ions. The significant reduction in
local pH solubilizes the inorganic constituent of bone and hydrolytically digests the organic
matrix.
The anabolic counterpart to an osteoclasts is the osteoblast. Osteoblasts line surfaces of
bone and express Type I collagen and other phenotypic markers, including osteocalcin, bone
sialoprotein and several other extracellular matrix proteins. The extracellular matrix produced
by osteoblasts is referred to as osteoid and acts as an interface between the osteoblast and host
bone. Osteoblasts are responsible for regulating the process of mineralization, which occurs in
two specific phases: nucleation and growth (Bolstrom et al., 2000). The nucleation phase of
mineralization consists of a local supersaturation of precipitating species, including Ca2+ which
is accomplished by extracellular secretion by osteoblasts.

Following the build-up of

precipitating species, nucleation sites are exposed on the osteoid extracellular matrix. The
nucleation of Ca2+ and PO4- groups is followed by a rapid accumulation and growth phase. The
addition of more hydroxyapatite crystals during this phase improves the rigidity of the substrate
and provides the structural basis of new bone formation.
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Osteocytes are another integral cell component of bone.

Osteocytes are actually

osteoblasts that have been completely surrounded by mineralized osteoid and are considered to
be the terminal phase of the osteoblastic lineage. Within a section of cortical bone, osteocytes
are distributed in concentric rings of the osteon. The immobile osteocytes communicate with
each other by extended cell processes that travel through the canaliculi of bone (Keaveny and
Hall, 1993). Osteocyte communication, which is both autocrine and paracrine (communicating
directly with osteoblasts on the bone surface) in nature can help to regulate the homeostasis of
bone and is implicated in one of the main driving forces of new bone remodeling (Bolstrom et
al., 2000).
Bone Remodeling
The function of osteoblasts and osteoclasts are coupled during the process of bone
remodeling by a distinct set of pathways. Bone remodeling is necessary for two distinct reasons:
1. maintenance of systemic (circulating) calcium concentrations and 2. optimization of bone
geometry and structure for adequate load bearing capacity. For the purposes of this discussion,
we will focus on the second reason. It is known that new bone forms and existing bone remodels
according to the mechanical loading that it experiences; a property known as Wolff’s Law. This
mechanism optimizes the geometric and material properties of bone based on predominant
loading amplitudes, frequencies and directions.

Even in skeletally mature humans, bone

continuously remodels as a function of body mass index, level of activity, diet and pathology.
While the exact mechanisms of how mechanical forces are converted to cell-level
communication are unknown, it is understood that the process is dependent on the coupling of
anabolic and catabolic activity by osteoblasts and osteoclasts, respectively. The functional
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coupling of these cells is accomplished through a variety of physicochemical and biochemical
signals. In terms of physical signaling, osteoclast-mediated bone resorption can be mediated by
osteoblast signaling.

Upon exposure to elevated levels of 1,25-dihydroxyvitamin D3,

osteoblastic lining cells are stimulated to contract, which exposes mineralized osteoid.
Activation of osteoclastic resorption requires exposure of mineralized matrix, as well as
exposure to matrix-bound proteins. Osteoblast surfaces express receptor activator for nuclear
factor- ligand (RANKL) (Bolstrom et al., 2000). RANKL is a cell surface protein that is
necessary for receptor activator for nuclear factor-- (RANK) induced activation of nuclear
factor- (NF-), as well as nuclear factor of activated T cells (NFATc1). Activation of NF and NFATc1 stimulates active resoprtion, as well as the recruitment and differentiation of
osteoclast precursors.

To inhibit resorption, other local osteoblasts begin to express

osteoprotegerin (OPG). OPG binds to RANKL on osteoblast surfaces, which eliminates NF-
and NFATc1 activation and brings the process of resorption to a halt. Active degradation of the
bone results in the release of growth factors with osteogenic activity, including bone
morphogetic proteins (BMPs), which are members of the transforming growth factor-beta (TGF) superfamily of proteins. Release of these growth factors from the matrix results in increased
matrix production by osteoblasts. As shown, the process of osteoclastic bone resorption and
osteoblastic bone formation is a continuous feedback loop relying with each cell relying on the
function of the other to maintain homeostasis.
Fracture Healing and Bone Regeneration
Despite the hierchical structure of human cortical and cancellous bone and the complex
cellular basis for homeostatic balance between anabolism and catabolism, bone is still prone to
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mechanical failure. Fractures accounted for over 20% of all reported musculoskeletal injuries in
2008 (www.boneandjointburden.org). Long bones of the upper and lower extremities are the
most common anatomic locations of these fractures, followed closely by fractures of the
vertebral column. Severe fractures are associated with significant physical limitations and the
greatest number of missed days of work compared to any other type of musculoskeletal injury
(www.aaos.org).
Bone is a tissue that does have a relatively potent intrinsic healing mechanism in the
event of fracture (Day et al., 2000). Depending on the magnitude, direction and mode of
loading, immediately upon fracture, there is a disruption in the structural aspect of the tissue, its
blood supply and surrounding soft tissues. Attending physicians attempt to reduce the fracture,
which involves the direct application of force to restore the normal anatomy of the fractured
bone. Depending on the type of injury, stability of the reduced fracture and anatomic location,
the extremity affected by the fracture may be placed in a cast to reduce mobility. In other
situations, open reduction and internal fixation (ORIF) is necessary. In the case of ORIF,
metallic implants, such as intramedullary nails or screw and plate constructs will be used to
create rigid fixation at the site of fracture. Both the quality of the fracture reduction and the
degree of fixation used dictate the healing response of the bone. Primary cortical healing is one
such healing response, which entails the attempt by the bone to re-establish osteon-osteon
contact between the fracture fragments. Gaps that persist between fracture fragments after
reduction become vascularized and a callus forms. The callus consists of a milieu of cytokines
which direct neoangiogenesis, facilitate cellular infiltration to the fracture site and provide the
biochemical impetus for healing. MSCs differentiate towards an osteoblastic lineage and begin
to express osteoid, which later becomes mineralized. These initial phases of osteogenesis occur
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in the absence of osteoclastic bone resorption, as the direct need is for tissue anabolism. Days
after this period of pure anabolic response at the fracture site, osteoclastogenesis occurs.
Osteoclasts activate and begin to chemically debride any non-viable bone at the fracture site.
The fracture callus is then resorbed and osteoblast-osteoclast coupling occurs to initiate the
process of remodeling. With an appropriately rigid reduction and fracture fixation, stresses and
strains will still be effectively transmitted to the tissue, as the patient is encouraged to begin
using the affected limb. Osteoclasts form cutting cones to remodel the newly formed bone to be
optimized for bearing of biomechanical loads (Bolstrom et al., 2000; Day et al., 2000).
Secondary healing is another mechanism by which fractures can heal. Unlike primary
healing, secondary healing does not involve the re-establishment of osteonal contact between the
fracture fragments.

Instead, a potent reaction by the bone’s outer sheath-like covering

(periosteum) immediate initiates the formation of a callus that covers the entire fracture site (Day
et al., 2000). The biochemical and biologic microenvironment of the callus contains a high
concentration of endogenous promoters of neoangiogenesis and osteogenesis. Host osteoblasts
in each of the fracture fragments are encouraged to excrete a collagenous extracellular matrix.
Secondary healing often involves bone formation by endochondral ossification. This method of
bone formation mimics embryonic bone formation and involves the formation of a collagenous
template by MSCs.

The collagenous template is subsequently mineralized to form highly

functional bone tissue in a relatively short period of time. Similar to primary healing, osteoclasts
begin to remodel the newly formed bone to ensure a return to normal weight bearing status with
minimal dysfunction.
The Need for Bone Grafting
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Despite the ability of bone to heal through a variety of intrinsic processes and pathways,
several clinical situations arise where the patient’s healing and regeneration response is
insufficient to provide a return of the bone to a normal structure. Measures are taken by
surgeons to restore the load bearing capacity of the bone by augmenting the site of bone injury or
dysfunction with biologic, or synthetic constructs. These constructs are meant to serve not only
as load bearing structures, but also scaffolds onto which the patient’s new bone will form.
Sometimes these constructs contain endogenous, or exogenous factors that promote the
recruitment of stem cells to the site to speed the rate and amount of new bone formation.
Regardless of the configuration, these constructs are referred to as bone grafts and are used quite
frequently in orthopaedic surgery.

In 2003, over 1 million bone grafting procedures were

performed in the United States alone (www.aaos.org).

While use of bone grafting in

musculoskeletal trauma situations is obvious, there are two other scenarios that account for a
significant portion of the number of bone grafting procedures performed each year. As both of
these scenarios have become increasingly more common, even over the last decade, it is
pertinent to discuss the application of bone grafting in these situations.
Bone Grafts for Osseous Neoplasms
The presence of malignant or benign neoplasms, or tumors, within osseous tissue is a
relatively common occurrence (Clohisy 2000). Several types of benign tumors exist, including
aneurysmal bone cysts, osteoid osteomas and osteochondromas.

Aneurysmal bone cysts

frequently occur as a result of a pre-existing bone tumor, which can lead to increases in local
blood flow.

This increase in local blood flow, as well as local blood pressure cause the

formation of a cyst in a location previously occupied by the bone tumor. These types of tumors
can arise on the surface of a bone, or remain confined within the marrow cavity. Osteoid
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osteomas are small focal lesions that tend to occur in the vertebrae and are characterized by a
dense area of random oriented (woven) bone, fibrovascular tissue with a focal area of osteolysis
(bone resorption) and a dense ring of sclerotic (non-viable) bone (Clohisy 2000).
Osteochondromas are tumors that present as osseous outgrowths on a bone. The outgrowth often
has a cap of cartilage at the most distal end and tend to affect the long bones of the extremities.
Malignant tumors of bone include osteosarcomas, Ewing’s sarcomas and secondary tumors
arising from metastatic cancer. Malignant tumors tend to be quite aggressive and destructive in
nature. Osteosarcoma is the most common primary osseous tumor and occurs frequently in the
pediatric population. Ewing’s sarcoma is another malignancy that tends to affect the adolescent
population and is characterized by an expansile lesion, usually found in the femur, humerus or
tibia.
Aside from presenting with constitutional symptoms (fever, chills, night sweats) and the
insidious onset of pain, another common clinical presentation of a bone tumor is fracture of a
bone from a seemingly low energy event. Frequently, a patient will describe falling from a
standing height and present with a fracture. Upon analysis of X-rays, the presence of a lesion is
in the region of the fracture is observed. The so-called “pathologic fracture” is a function of the
structural compromise of a bone affected by either a benign or malignant tumor (Day et al.,
2000). All of the above-described benign and malignant tumors are associated with focal
disruption of cortical bone in load bearing anatomic locations, including the vertebrae, femur,
tibia and humerus. Disruption of the cortices creates a stress riser in the bone, which can lead to
compression fractures in the spine, or transverse and oblique fractures in long bones.
In a setting where an osseous tumor is discovered prior to pathologic fracture by X-ray,
computed tomography (CT) or bone scintigraphy, treatment often involves surgical excision of
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the lesion. Debridement of a wide margin of bone accompanies excision of the lesion, in an
attempt to remove the full extent of malignant or non-normal tissue. Because of both the
excision and debridement, the bone still remains susceptible to fracture through the original site
of the tumor. Extremely aggressive tumors can also compromise the integrity of a an entire
region of bone, necessitating radical resection of entire sections of bone to prevent spread of
malignancy.
In addition to surgical excision of the bone tumor, radiation and/or chemotherapy is
frequently employed to reduce the size and viability of a tumor. Post-operative radiation is often
used to ensure that the, even when wide margin excision or resections are performed, the
tumorous tissue will not return. Radiation and certain types of chemotherapy have been shown
to alter the biology within bone. Further evidence exists which details the effect of radiation on
local MSC populations in terms of their ability to differentiate towards an osteoblastic lineage
and, ultimately, to repair bone. Chemotherapeutic agents, such as methotrexate and Adriamycin
have been shown to alter systemic bone formation dynamics, leading to an uncoupling between
osteoclastic bone resorption and osteoblastic bone formation. Georgiou, et al. demonstrated the
effect of methotrexate on the differentiation capacity of marrow-derived MSCs in a rate model.
In animals treated with methotrexate, MSCs were more likely to differentiate towards an
adipogenic lineage, rather than an osteoblastic lineage.
As described, the presence, as well as the treatment of osseous neoplasms results in a
challenging clinical situation in terms of affecting bone healing. The excision of a bone tumor,
or resection of an entire section of bone creates a critical defect that necessitates the use of a
bone graft construct to support biomechanical loading. Pre- and post-operative radiotherapy
and/or chemotherapy can have a negative effect on the potential of the patient to rapidly

15

regenerate bone at the site of excision. As such, the bone graft employed must present a surface
and morphology conducive to bone formation. Additional agents, endogenous or exogenous,
locally or systemically administered may be necessary to induce the rapid formation of bone at
the grafting site.
Hariri, et al recently described the use of a free vascularized fibular graft for
reconstruction of metadiaphyseal bone of the femur and tibia following resection for expansile
neoplasms, such as Ewing’s sarcomas (Hariri et al., 2010). The graft was harvested from the
fibula on the same side as the femur affected by the tumor. This type of graft provides excellent
load bearing support, due to the high ratio of cortical to cancellous bone. In addition to load
bearing support, this graft also contains fresh vascular tissue, which aids in the formation of a
callus.

Callus formation precedes new bone formation due to the high concentrations of

osteoinductive proteins and chemotactic agents for MSCs (Day, 2000)
Bone Grafts for Spine Fusion
Spinal arthrodesis, also known as spinal fusion, is a procedure which relies on the
creation of a bony bridge between adjacent vertebrae, as shown in Figure 3. Spine fusion is
indicated for the treatment of both acute and chronic conditions of the spine, such as
intervertebral

disc

herniation,

degenerative

disc

disease,

spondylolisthesis

and

spondyloarthropathy (DePalma et al., 1972; Hu and Bohlman, 1994; Malloy and Hilibrand,
2002).

These conditions most often involve impingement of neurovascular structures by

herniated intervertebral disc tissue, or vertebrae which have translated too far in relation to
adjacent vertebrae. Patients experiencing this impingement may present clinically with radiating
pain (radiculopathy) throughout an extremity, numbness, tingling, loss of motor function and
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even cognitive deficits (DePalma et al., 1972). Other patients will present with debilitating axial
back pain, which is confined to the midline of the spine without any radicular symptoms.

Figure 3. Illustration of common intervertebral disc pathology leading to pain and
dysfunction (right) and the technique of interbody fusion (right). Image taken from
www.orthogate.com/spine.

Treatment of the symptomatic spine level involves the formation of a bony bridge
between adjacent vertebrae. The spine level is fused to restore the normal lordotic or kyphotic
curvature of the spine, while increasing stability of the segment, thus reducing the incidence of
future compromise of neurovascular structures, pain and dysfunction. In the case of interbody
fusion, arthrodesis is created between the vertebral bodies of adjacent vertebrae (DePalma et al.,
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1972).

This procedure involves making an incision to the outer annulus fibrosus of the

intervertebral disc. Once access is gained through the annulus fibrosus, the nucleus pulposus and
inner annulus fibrosus tissue is removed by rongeurs and suction. The endplates of the vertebral
bodies within the intervertebral disc space are decorticated to yield bleeding bone, which
theoretically aids in the migration of mesenchymal stem cells from the marrow cavities in the
vertebral body. Bone graft material is then placed between the vertebral bodies to maintain
distance between vertebrae (disc height) and to induce and/or facilitate the growth of new bone,
thus stabilizing the spine segment, as shown in Figure 4. Depending on the technique used, a
metallic plate may be placed in the anterior portion of the spine to prevent extrusion of the bone
graft material, which, in the case of interbody fusion of the cervical spine, could cause damage to
vital structures such as the trachea.
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Figure 4. X-ray of a patient who underwent cervical interbody fusion.
In applications, such as interbody fusion, the bone graft material must be capable of
withstanding substantial static compressive loads, as well as cyclic compression, bending and
torsion (DePalma et al., 1972; Lippman et al., 2004; Shikinami and Okuno, 2003). While the
biomechanical loading within the long bones of the extremities and in the spine are significant,
the mechanical properties of the bone graft should not exceed that of native bone. Specifically, if
the elastic modulus of a bone graft material greatly exceeds the elastic modulus of the bone that
it is replacing, a phenomenon known as stress shielding may occur. Stress shielding is the result
of ineffective load transmission to growing bone, due to the mismatch in static mechanical
properties. Stress shielding renders bone growth slow and random according to Wolff’s Law and
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frequently results in the formation of fibrous tissue, which is not conducive to load bearing
(Shikinami and Okuno, 2003).
In addition to the mechanical requirements of a bone graft material, numerous basic and
translational science studies have described the importance of bone graft porosity.
Interconnected pores with an average diameter of 250 m have been shown to facilitate cellular
infiltration and neovascularization, which are critical components to bone growth (Georgiou et
al., 2007; Kruyt et al., 2004; Mathieu et al., 2005). Appositional bone growth, such as that which
occurs on the outside edges of a dense construct, is not capable of bearing the high compressive
loads in long bones of the extremities or in the spine. A final requirement of a bone graft
material is the ability to induce bone formation; a property referred to as osteoinductivity (Buck
et al., 1989; Fini et al., 2004; Malloy and Hilibrand, 2002; Wigfield and Nelson, 2001; Wimmer
et al., 2001). In biologic materials, this property is mediated by endogenous biomolecules (i.e.
growth factors) and pluripotent cells. The process of osteoinduction begins with chemotactic
recruitment of progenitor cells and the subsequent differentiation of these cells to an osteoblastic
lineage.

The differentiated cells then form a collagenous matrix, which is subsequently

mineralized resulting in the formation of bone.
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CHAPTER 2:BONE GRAFT MATERIALS - FROM AUTOLOGOUS TO SYNTHETIC
Background
Bone grafting was first attempted and reported in 1668 in the Netherlands by Dr. van
Meekeren. This surgeon described the repair of a soldier’s traumatic cranial defect with bone
harvested from a canine skull. Nearly 250 years later, Dr. Albee described the use of autologous
bone harvested from the lower extremity in achieving successful spine fusion. Later that century
as autologous bone grafting gained popularity, surgeons began attempting to isolate the growth
factors from harvested bone to enhance fracture healing. Dr. Urist, in 1965, was the first to
isolate bone morphogenetic proteins from bone and later described the process by which these
proteins led to bone formation by a process he termed “autoinduction.”
The technique of bone grafting is now an extremely common adjunctive procedure
performed in a variety of surgical scenarios to ensure rapid, complete healing of injured, or
pathologically compromised bone.

Today, more than 1 million procedures are performed

annually in the United States which involve the use of bone graft materials. A sizeable market
now surrounds bone graft and bone graft substitute materials, which generates in excess of $2.5
billion in sales per year. These numbers are continuing to climb as the average life expectancy
of humans increase while simultaneously, the average age of orthopaedic patients decreases
creating an ever-increasing demand.
Despite significant progress in the techniques and materials used for bone grafting, as
well as the increasing frequency with which these procedures are performed, there is still a
substantial amount of room available for improvement. Regardless of the use of cutting-edge
recombinant human proteins and novel material processing methods, non-union (failure of bone
formation) still persists as a common complication associated with bone grafting. A comparison
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of currently used materials, from biologic to synthetic, is presented with the intention of
identifying the multi-factorial requirements of bone graft materials, advantages with specific
clinically-used constructs and disadvantages which lead to clinical failure. Since the focus is on
bone graft materials used strictly for structural or load bearing applications, the discussion of
various types of bone graft materials is focused nearly exclusively on graft materials used in
spine fusion procedures.
Requirements of Bone Graft Materials
The mechanical strength of bone graft materials, is of primary importance as these
constructs are meant to replace sections of bone damaged by trauma or biochemically altered by
pathology. Initial mechanical properties of the construct must be sufficient to support both static
and dynamic loading in a variety of configurations, including compression, bending and torsion.
Depending on the anatomic location, compressive loading in a long bone of the lower extremity
can exceed several times body weight for common activities of daily living, such as jumping,
walking down a flight of stairs and running (Day et al., 2000; Keaveny 1993). While it is
important for the bone graft constructs to support biomechanical loading by possessing adequate
mechanical properties, it is equally important that the stiffness, or modulus of the material does
not greatly exceed that of the bone that the construct is attempting to replace. When a material
with an elastic modulus that greatly exceeds that of the host bone is implanted, a process known
as stress shielding is likely to occur. Stress shielding is a phenomenon that results in new bone
formation being slowed and random, in terms of its structure. Both new bone formation, as well
as bone remodeling require the adequate transmission of load to the cells responsible for forming
the tissue. If a bone graft construct has an elastic modulus that greatly exceeds that of the bone it
is replacing, the construct itself absorbs the vast majority of the biomechanical loading without
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effective transmission to the newly forming bone. According to Wolff’s Law, bone growth
happens in a manner proportional to the stresses and strains that the bone experiences (Day et al.,
2000). Without effective load sharing between the bone graft material and host bone, newly
formed bone will be incapable of supporting biomechanical loads and will most often take on a
fibrous appearance. Stress shielding often requires a revision procedure to correct the problem
(Day et al., 2000; Keaveny 1993).
Constructs used as bone graft substitute materials should also possess characteristics
conducive to their controlled resorption in vivo. A goal of bone grafting is to use a construct as a
temporary load bearing structure and scaffold for new bone formation. The bone graft material
is intended to be eventually replaced by host bone. The temporary nature of a bone graft
construct obviates the problems associated with permanent devices, which include an
omnipresent risk of infection.

Additionally, permanent constructs, depending on their

composition and properties, may complicate future surgeries that the patient may need. For
instance, the presence of a large synthetic scaffold used to heal a femur fracture, may create a
difficult obstruction to the proper placement of a total hip replacement component that the
patient may need several years later. Non-resorbable materials used for bone graft application
may also interfere with radiographic imaging, which is used to assess healing post-operatively.
An obvious goal of bone grafting is to encourage new bone formation. Autograft has the
capability of inducing new bone formation, a process known as osteoinduction, due to
endogenous growth factors and mesenchymal stem cells (MSCs).

This process was first

described by Urist, et al. who examined bone formation due to “autoinduction” following
implantation of demineralized bone matrix (Urist, 1965). This group identified endogenous
growth factors, such as bone morphogenetic protein-2 (BMP-2), transforming growth factor-beta
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(TGF-) and platelet-derived growth factor (PDGF) as some of the main proteins involved in the
process. These proteins are chemotactic for mesenchymal stem cells. Once recruited to the site,
the MSCs begin to differentiate towards an osteoblastic lineage. A collagenous extracellular
matrix is deposited and subsequently mineralized by host osteoblasts, as well as recently
differentiated MSCs. Currently, recombinant technology is used to synthesize human BMP-2
and BMP-7 for the purposes of enhancing bone formation following fracture or in the setting of
spine fusion. These growth factors can be used to confer the attribute of osteoinductivity to bone
graft materials of all types, including synthetic constructs. Another method used to encourage
bone formation is the use of bone marrow aspirate. Bone marrow is known to contain MSCs, as
well as a complex milieu of biochemical factors that are capable of inducing bone formation.
The use of bone marrow aspirate is accomplished via a needle biopsy of an anatomic location
known to contain a significant volume of bone marrow and marrow-derived MSCs. The iliac
crest, vertebral bodies and proximal humerus are common locations for harvesting bone marrow
aspirate. The aspirate is then applied to the site of intended bone formation.Numerous clinical
and pre-clinical trials exist outlining the success of these osteoindutive techniques.
The property of osteoconductivity is another important requirement of bone graft
materials. This attribute refers to the ability of a construct to facilitate, rather than induce, new
bone formation.

Numerous factors contribute to the development of osteoconduction of a

material. Scaffold materials should be porous to facilitate cellular infiltration within the three
dimensional structure of the graft. If cells are unable to penetrate a construct, appositional bone
growth may occur. Appositional bone growth is the generation of a ring of bone that forms
along the outside of the graft constructs, rather than throughout the entire load bearing structure.
Appositional bone growth is insufficient to support biomechanical loads, especially when the
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graft material is designed to resorb over time in vivo. If bone is to grow throughout the three
dimensional structure of a graft construct, there must be a method to facilitate nutrient transport
to the center of the graft to keep cells healthy and to continue the process of bone formation and
maturation. Nutrient transports is accomplished by the generation of microvasculature at the site
of bone healing. An average pore size of 100-300 m has been shown to be adequate to support
the development of neovascularization and efficient microvascular infiltration of three
dimensional constructs.

In addition to a porous microstructure, surface chemistry and

topography of the scaffold has also been shown to be an important contributor to osteoblast
attachment and proliferation. surfaces promote osteoblas
Autologous Bone Graft
Autogenous iliac crest bone graft, shown in Figure 1, has been used extensively in
cervical, thoracic and lumbar interbody spine fusion procedures with a high degree of clinical
success.

Despite the success rate of the spine fusion procedures, harvest of autograft bone is

associated with numerous harvest site complications (Buck et al., 1989; Hu and Bohlman, 1994;
Malloy and Hilibrand, 2002; Samartzis et al., 2005; Wigfield and Nelson, 2001; Wimmer et al.,
1999; Zdeblick and Ducker 1991). Donor site complication rates as high as 20-30% have been
reported after performing iliac crest graft harvest procedures (Hu and Bohlman, 1994; Malloy
and Hilibrand, 2002; Wigfield and Nelson, 2001). An iliac wing fracture rate of 7% was
reported by Hu and Bohlman when harvesting for spinal fusion procedures (Hu and Bohlman,
1994).

Even if the patient does not present postoperatively with symptoms of donor site

morbidity, fracture initiating from the harvest site, or infection, DePalma and others found that
the incidence of pain after iliac crest graft harvest was as high as 36% (DePalma et al., 1972).
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Exposure of the patient to this additional procedure of graft harvest also increases the likelihood
of infection.

Figure 1. Anterosuperior harvest location for iliac crest bone graft. American Journal of
Sports Medicine.

Allogenic Bone Graft
Due to the high rates of post-operative complications associated with the harvest of
autograft bone, allogenic bone (allograft) has been proposed as an alternative (Malloy and
Hilibrand, 2002; Samartzis et al., 2005; Wimmer et al., 1999). Allograft is bone harvested from
a donor, usually at the time of death. The bone is aseptically harvested from the donor, sterilized
and stored in a freeze-dried state in a tissue bank. A number of reports in the literature have
shown an increase in the use of allograft in spinal fusion applications. In 1991, Zdeblick and
Ducker experienced only a 78% rate of cervical arthrodesis when using allograft, as compared to
92% who received autograft (Zdeblick and Ducker, 1991). Similarly, Nugent and Dawson

29

reported a lumbar fusion rate of only 70% with allograft, compared to 92% with iliac crest
autograft (Nugent and Dawson, 1993). Recently, fusion procedures implementing allograft have
achieved rates of fusion comparable to those using autograft. In 2005, Samartzis and others
achieved a 100% rate of cervical arthrodesis with allograft.

They found no statistically

significant difference in the fusion rates between allograft and autograft (Samartzis et al., 2005).
Functional outcomes are also slightly higher for allograft groups due to the elimination of harvest
site complications associated with autograft harvest.
However, numerous disadvantages of allograft usage exist.

While careful donor

screening and sterilization procedures have reduced the incidence of disease transmission,
reports still surface. Specifically, the transmission of Hepatitis and HIV associated with allograft
bone have been reported in the literature (Buck et al., 1989). Additionally, the same sterilization
procedure that reduces the risk of disease transmission has also been shown to reduce the
osteoinductivity of the graft (Malloy and Hilibrand, 2002; Samartzis et al., 2005; Wigfield and
Nelson, 2001). Sterilization methods, such as gas plasma, ethylene oxide and gamma irradiation
have been shown to have an effect on the concentration and efficacy of osteoinductive proteins
endogenous to allograft. Denaturation of these proteins compromises the ability of allograft
bone to induce desired bone formation. In addition to reduced osteoinductivity, allograft bone is
subject to the finite supply of donor tissue. Tissue banks in the European Union, as well as the
United States have reported shortages of allograft tissue (Wigfield and Nelson, 2001; Wuisman
and Smit, 2006; Zdeblick and Ducker, 1991). Further, allograft is much less available in rural
and geographically isolated hospitals.
Clinically-Used Bone Graft Substitutes
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Among the first substitutes explored were the calcium phosphates, particularly
hydroxyapatite. Hydroxyapatite (HA) is a ceramic material that is compositionally similar to
native bone mineral, with a calcium to phosphorus ratio of 1.67. HA that is currently in use is
derived from sea coral, which is composed of calcium carbonate (Suetsuna et al., 2001; Zdeblick
et al., 1994). The calcium carbonate undergoes a hydrothermal conversion to HA. The end
result is a highly interconnected porous structure that compositionally and morphologically
mimics cancellous bone. Coralline HA has been used clinically in interbody spinal fusion
procedures.

While corraline HA is an effective osteoconductive scaffold, it lacks the

osteoinductive potential of autograft and allograft, which has resulted in inferior performance.
Further, complications associated with fracture of the brittle ceramic have been reported. These
brittle failures result in reduced intervertebral disc height and subsequent compromise of
neurovascular structures, necessitating immediate revision surgical procedures (Suetsuna et al.,
2001; Zdeblick et al., 1994).
Calcium phosphates have also been used in particulate form for spinal fusion procedures.
Several phases of particulate calcium phosphates are in current clinical use, including betatricalcium phosphate (-TCP), HA and dicalcium phosphate dihydrate (DCPD). The porosity,
surface chemistry and composition have been shown to facilitate bone growth. However, the
particulate materials lack load-bearing capacity and therefore must be used with additional
instrumentation, such as fusion cages. These cages act as the load bearing component and also
facilitate containment of the calcium phosphate material. The mechanical properties of these
cages, specifically the modulus of elasticity, exceeds that of native bone. This results in the
previously mentioned phenomenon of stress shielding, which renders bone growth slow and
random.
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To address the brittle nature of coralline HA and the non-load bearing capacity of
particulate calcium phosphates, porous metal constructs have recently been introduced (Wigfield
and Nelson, 2001).

The metallic constructs are fabricated using a number of different

techniques, all resulting in the formation of highly porous structures resembling the architecture
of cancellous bone. The metals used, including tantalum, pure titanium and titanium alloys, have
mechanical properties that make them capable of withstanding physiologic loading. The open
porous morphology of the construct decreases the bulk elastic modulus, reducing the incidence
of stress shielding with these metals. However, these porous metal constructs have not found
great clinical acceptance in spine fusion procedures.

The non-resorbable nature of metals

presents an omnipresent risk of infection to the patient. Non-resorption also limits the options of
a surgeon who is performing a revision procedure on the patient. Metallic constructs also present
a challenge to imaging modalities, such as computed tomography (CT) and magnetic resonance
imaging (MRI).

The radiopacity of metals, can also reduce the accuracy of radiographic

assessment of bone growth and fusion.
Collagen-based sponges have shown a great deal of promise recently as bone graft
substitute materials (Wigfield and Nelson, 2001). These sponges are composed primarily of
bovine type I collagen and may (HEALOS, Depuy Spine; CRM, Medtronic Inc.) or may not
(INFUSE, Medtronic Inc.) be reinforced with calcium phosphates. Collagen sponges have a
fibrous structure with a high degree of interconnected porosity and are completely resorbablein
vivo.

These constructs have been used in spine fusion, primarily for the delivery of

osteoinductive growth factors, such as recombinant human bone morphogenetic protein-2 and -7
(rhBMP-2, rhBMP-7 or OP-1).

While the growth factor-collagen sponges constructs have

enjoyed widespread success, they still lack the ability to support biomechanical loading as a
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standalone implant. As such, they must be used in conjunction with permanent hardware, such
as titanium or poly ether ether ketone (PEEK) fusion cages.
Resorbable Polymers as Emerging Candidates for Bone Graft Substitute Applications
Resorbable polymers, such as poly-L-lactic acid (PLLA) and poly-L-glycolic acid
(PLGA), have been investigated for use as bone graft substitute materials (Georgiou et al., 2007;
Kruyt et al., 2004; Mathieu et al., 2005; Tsuji et al., 2003; van Dijk et al., 2003).

While not

currently used for this application clinically, these materials have shown excellent
biocompatibility and resorb predictably in vivo.

Degradation is dominated by hydrolytic

cleavage of ester linkages in the polymer backbone. The byproducts of degradation are lactic
and/or glycolic acid, which are easily metabolized in vivo to pyruvate, water and carbon dioxide.
Controlled degradation of the polymer has been shown to facilitate slow release of therapeutic
substances, such as growth factors used to induce bone formation.
As previously stated, an interconnected porous morphology is a requirement of bone graft
substitute materials. The porous morphology supports cellular infiltration and nutrient transport
affected by neovascularization. Numerous methods have also been shown to be effective in
synthesizing porous constructs from PLLA and PLGA polymers, including thermal-induced
phase separation, particulate leeching and three dimensional free-form fabrication techniques.
These techniques require the use of volatile organic solvents, such as chloroform or
dichloromethane, to dissolve the polymer. Even after several hours under vacuum, residual
levels of organic solvent persist within the material. These solvents leech from the construct
when it is placed in an aqueous environment and can induce an inflammatory response.
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Evidence also exists supporting the claim that organic solvent content can also induce a cytotoxic
response, both in vitro and in vivo.
Despite all of the potential benefits of resorbable polymer constructs, limited mechanical
strength, especially of porous constructs, has kept PLLA and PLGA from clinical use in
structural bone graft substitute applications. Numerous filler materials have been investigated as
agents to mechanically reinforce porous resorbable polymer matrices.

Calcium phosphates

including HA and -TCP have shown efficacy in increasing the mechanical strength of porous
PLLA and PLGA constructs. Calcium phosphates also increase bioactivity of the constructs, by
enhancing osteoblastic adhesion and differentiation. Single and multi-walled carbon nanotubes
have also been used to reinforce porous PLLA and PLGA constructs. Despite the numerous filler
materials investigated to reinforce the mechanical properties of porous resorbable polymer
matrices, compressive strengths of these constructs are still below the threshold required for
spine fusion applications. This lack of reinforcement efficacy has been attributed to poor fillerpolymer matrix interaction. It has also been observed that current techniques employed to
disperse fillers in resorbable polymers are not able to overcome the agglomeration of small
particles.

Agglomerated particles within a polymer matrix lead to reduced mechanical

properties. Additionally, a lack of positive interaction between the polymer chains and the filler
particles results in poor restriction of polymer chain mobility, which is a necessary component of
reinforcement in polymer matrix composites.
Resorbable polymer nanocomposites demonstrate a significant amount of promise as
bone graft substitute materials. To overcome current challenges associated with nanocomposite
technology, a novel material formulation and synthesis route is needed. The proposed method
must ultimately result in a resorbable construct with an interconnected porous morphology,
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which is capable of supporting new bone formation, as well as withstanding biomechanical
loading.
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CHAPTER 3: POLYMER-MONTMORILLONITE CLAY NANOCOMPOSITES
Background
Resorbable polymers show promise as potential materials for use as synthetic bone graft
substitute materials. Their predictable degradation in vivo and track record of biocompatibility in
multiple forms speak to this promise. Unfortunately, the mechanical properties of resorbable
polymers with a porous morphology are not sufficient for load bearing applications in the human
spine or long bones of the extremities. Due to this poor mechanical behavior, there is significant
interest in developing a composite material. Successful creation of a composite material would
still allow physicians to take advantage of the desirable physical and chemical properties of the
polymer, while reinforcing the matrix with a functional filler material. Further, since bone is
essentially a composite material (collagen matrix reinforced by hydroxyapatite) it is logical to
replace that tissue with a synthetic composite material.

Nanocomposites consisting of a

polymeric matrix reinforced by layered silicate fillers are a strong candidate for bone graft
substitutes. Specifically, lactic or glycolic acid-based polymers reinforced with organically
modified Montmorillonite clays (nanoclay) are promising options for this biomedical
application. The exceptional improvements in mechanical properties associated with loading
polymer matrices with nanoclays have stimulated a significant amount of research for nonbiomedical applications, as well.
Structure of Montmorillonite Clay
Montmorillonite clays are naturally-occurring layered aluminosilicate minerals that are
the main constituent of Bentonite, which is found in volcanic ash. The structure of the clay is
characterized by an octahedral sheet sandwiched by two tetrahedral sheets. The octahedral sheet
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is composed primarily of aluminum oxide, while the tetrahedral sheets are primarily silicon
oxide (Pavlidou and Papaspyrides, 2008). Aluminum atoms within the octahedral sheet can be
substituted with other cations, which require a positive charge to balance the structure. This
positive charge often comes in the form of an alkaline earth cation (most often Na+, in
Montmorillonite), which reside on top of the tetrahedral sheet (Ray and Okamoto, 2002). The
thickness of a single layer of Montmorillonite is approximately 1 nm, while the width can vary
from 30 nm to several microns, giving the clays an extremely high aspect ratio and thus a very
high reinforcement capacity in polymer matrices. As is the case with many aluminosilicates, the
tetrahedral-octahedral-tetrahedral structure repeats to form a layered structure with a regular van
der Waals gap between layers, referred to as the gallery spacing (Pavlidou and Papaspyrides,
2008).

Clays can be organically modified to increase the spacing between layers via ion

exchange with cationic surfactants, such as alkyl ammonium salts. The increase in intergallery
spacing improves the dispersion of nanoclay within polymeric matrices and reduces the
likelihood of particle agglomeration, which can negatively impact mechanical behavior (Horsch
et al., 2006).
Polymer-Clay Nanocomposites
Polymer-nanoclay nanocomposites were first introduced by Toyota in the 1990’s and
were based on Nylon-6 reinforced with unmodified Montmorillonite clay (Pavlidou and
Papaspyrides, 2008; Ray and Okamoto, 2002). Numerous processing methods exist to disperse
natural and organically modified Montmorillonite clays within polymer matrices. Regardless of
the method, the overall goal remains the same: maximize polymer nanoclay interaction to reduce
polymer chain mobility, thus enhancing static and dynamic mechanical properties. In order to
maximize polymer-clay interaction, processing methods are aimed at delaminating the layered
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silicate structure into individual clay platelets (1 nm x 30 nm), which are subsequently dispersed
in a random orientation throughout a polymer matrix. Delamination and dispersion of the
layered structure of clay is accomplished by infiltration of the intergallery space by polymer
chains. Infiltration of polymer chains may be significant enough to cause delamination of the
layered structure resulting in individual clay platelets dispersed throughout the matrix. Increased
motion of the polymer chains within the intergallery space during high-shear mixing may also
encourage delamination and dispersion of clay platelets.
There exists three different classes of polymer-layered silicate nanocomposites, which are
based on the extent of dispersion of clay platelets in the polymer. The first type is known as an
intercalated nanocomposite and is characterized morphologically by infiltration of polymer
chains within the intergallery space of the clay. The infiltration of the polymer increases the
intergallery spacing of the clay, but does not result in delamination of the layered structure.
Intercalated morphologies lend themselves to both strong polymer-clay interaction, as well as
considerable nanoclay-nanoclay interaction since the layered structure has not become
completely delaminated. Intercalated nanocomposites typically exhibit a high elastic modulus
(tensile), significantly reduced ultimate strength and improved fracture toughness.

The

improvement in fracture toughness is thought to be related to the increased surface area,
associated with intercalated morphologies. A second class of nanocomposites, which is closely
related to the intercalated morphology, is termed flocculated.

Similar to intercalated

nanocomposites, polymer chains have infiltrated the intergallery space, but have not resulted in
platelet delamination and subsequent dispersion. The main difference between intercalated and
flocculated nanocomposites is the interaction between whole clay particles within the polymer
matrix. In flocculated nanocomposites, clay particles, each consisting of a layered structure,
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interact with each other leading to flocculation or agglomeration of the particles within the
matrix.

Interaction between clay particles is mediated by the hydroxylated silicate layers.

Flocculated nanocomposites have mechanical property changes similar to that of intercalated
nanocomposites, but tend to have lower ultimate strength and stiffness. These similarities arise
from the fact that there is still significant infiltration of polymer chains within the layered
structure of the nanoclay. However, flocculation of the particulate within the polymer matrix
often leads to significant variation in properties due to non-uniform dispersion of the clay within
the matrix. Non-unifiorm dispersion is attributed to nanoclay-nanoclay interaction, which leads
to the development of clay-rich and clay-poor regions of a nanocomposites construct. The final
class of nanocomposites is the exfoliated structure. This morphology is characterized by clay
particles with layered structures that have been completely delaminated and dispersed at random
throughout the polymer matrix, as shown in Figure 1. In exfoliated nanocomposites, polymer
chain infiltration and subsequent interaction overcome platelet-platelet attraction resulting in
complete delamination and dispersion of individual clay platelets throughout the matrix.
Exfoliated nanocomposites typically exhibit significant increases in both static and dynamic
mechanical properties, even at low clay loading levels.

Exfoliated nanocomposites do not

exhibit as significant of improvements in fracture toughness when compared with intercalated
nanocomposites.

However, the random orientation of individual clay platelets within the

polymer matrix does result in toughening compared to native polymer structures.
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Figure 1. Illustration of clay platelet morphology in intercalated (A), intercalated-flocculated
(B) and exfoliated (C) polymer-clay nanocomposites.
Supercritical CO2 Processing of Polymer-Clay Nanocomposites
To achieve the various morphologies of polymer-clay nanocomposites, a number of
processing methods have been employed including in situ polymerization, melt intercalation,
extruding and solvent processing (Pavlidou and Papaspyrides, 2008; Ray and Okamoto, 2002).
Another method of processing exists, which utilizes supercritical carbon dioxide as the solvent
for processing (Horsch et al., 2006; Manitiu et al., 2008). Supercritical carbon dioxide (scCO2)
processing is technique that is growing in popularity in terms of its use in the creation of
polymer-clay composites.

scCO2processing involves mechanical mixing of nanoclays with

polymers. The subsequent mixture is poured into a mold and placed inside of a sealed, highpressure reactor vessel. The vessel is then filled with CO2 from a high pressure source. The
internal temperature and pressure of the vessel is then elevated to bring the CO2 to the
supercritical region of the temperature-pressure phase diagram. In this region, CO2 has the
excellent mass transfer characteristics, as simultaneously possesses the density of the liquid state
and diffusivity of the gas state. Elevation of the CO2 to the supercritical region also increases the
solubility of many polymer systems. During saturation and subsequent temperature-pressure
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elevation, the polymer becomes solvated within the reactor vessel. CO2 also diffuses into the
intergallery region of the clay particles, as solvated polymer chains also infiltrate the layered
structure. After a specified duration of exposure to the supercritical fluid, the reactor vessel is
rapidly depressurized, inducing a thermodynamic instability within the polymer-clay mixture.
Rapid CO2 bubble nucleation and growth, as well as polymer chain infiltration, delaminate the
layered structure of the nanoclay and uniformly disperse the filler throughout the matrix (Horsch
et al., 2006; Manitiu et al., 2008).

Proposed Use of scCO2 Processing to Create Synthetic Bone Graft Substitute Materials
While scCO2 processing has been used primarily in the synthesis of polymer
nanocomposites for automotive and textile applications, it may be useful in the development of
synthetic bone graft substitute constructs (Baker et al., 2009; Baker et al., 2011). The proposed
material would be composed organically modified nanoclay dispersed in a poly-D-lactide
(PDLA) matrix, with an interconnected porous morphology.

The hypothesized method of

synthesis includes mechanical mixing of as-received, organically-modified Montmorillonite clay
with particles of PDLA in a mold. The mixture would be placed in a high pressure reactor
vessel, and subjected to CO2 at elevated temperatures and pressures. Following a specific
duration of saturation, the system would be depressurized.

Catastrophic depressurization

delaminates the layered platelet structure of the clay, as previously described. In addition to
delamination of clay platelets, CO2 bubble nucleation and growth will take place during
depressurization.

As the structure solidifies, the coalescence of CO 2 bubbles yields an

interconnected porosity throughout the construct.

Both pressure of the composite material
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expanding against the mold, as well as heat transfer characteristics of the mold will contribute to
the formation of a dense shell, resembling the structure of cortical bone.

This shell will

transition abruptly to a porous core, which resembles the interconnected porous morphology of
cancellous bone. The resulting construct will mimic the dense-porous morphology of corticocancellous grafts used in structural bone grafting applications. In vivo, it is proposed that the
porous core will facilitate three-dimensional cellular infiltration by osteoprogenitor cells. The
average pore diameter will also be sufficient to support neovascularization that is necessary for
nutrient transport throughout the construct. The dense “cortical” shell of the construct will
support biomechanical loading in a manner similar to cortico-cancellous bone graft.
Supercritical CO2 processing has been used by other researchers to create porous
polymeric scaffolds and even composite materials (Georgiou et al., 2005; Mathieu et al., 2008).
Mathieu et al. synthesized poly(L-lactic acid) foams reinforced with calcium phosphate
particulate. From the same group, Georgeiou, et al. used scCO2 processing to create phosphate
glass-reinforced porous PLLA constructs. In both instances, considerable improvements in in
vitro biologic response was observed. However, both studies demonstrated only modest gains in
static mechanical properties. The authors attributed this to poor dispersion of the filler materials
within the resorbable polymer matrix. It is hypothesized that increased positive interaction
between the polymer chains and filler material will result in improved dispersion, which should
lead to uniform structural properties.
A key aspect of the scCO2 process that makes it especially attractive for the application
of creating bone graft substitutes is the ability to impart a porous morphology to the constructs.
Pores in the construct arise from the nucleation of CO2 bubbles within the solvated polymer upon
depressurization of the vessel. In a pure polymer construct, the formation of pores follows a
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classical homogenous nucleation model.

However, when processing nanocomposites,

heterogeneous nucleation of CO2 bubbles dominates. As described by Tomasko, the rate of
heterogeneous nucleation can be described by classical heterogeneous nucleation theory, as
described below:
N = f1C1exp[-G*het/kT]

[1]

where f1 is the gas frequency factor and C1 is the concentration of nucleation sites. For the
purposes of a polymer-clay nanocomposite processed by scCO2, C1 is proportional to the
concentration of clay platelets within the polymer. In this Ahrennius eqution, k is also the
Boltzmann constant and T is absolute temperature. The Gibb’s free energy of heterogenous
nucleation (G*het) is a function of the interfacial tension between the supercritical fluid and
polymer-clay mixture (), supersaturation of the mixture with CO2 (P = Psaturation – Pactual) and
the three component contact angle () at the polymer-clay-fluid interface.

G*het can be

expressed as:
G*het = 163f()/(3P2)

[2]

where,
f() = ¼(2+cos)(1-cos)2

[3]

From these equations (Eq. 1, Eq. 2 and Eq. 3), it can be seen that scCO2 processing parameters
can play an important role in determining the porous morphology of bone graft substitute
materials.

Specifically, the alteration of saturation pressure, processing temperature and

effective clay concentration should have a significant effect on the rate of bubble nucleation.
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The C1 term in Equation 1 actually shows a dependence of the nucleation rate on the
dispersion of clay within the polymer matrix. Fully exfoliated nanocomposites would have a
higher concentration of nucleation sites, compared to intercalated, or intercalated-flocculated
nanocomposite morphologies. As Zeng, et al. found, an increased number of nucleation sites in
well-dispersed PMMA-clay nanocomposites results in the formation of a material with a high
degree of total porosity and pores with a small average diameter (Zeng et al., 2003).
Supercritical CO2 processing is a promising method for the rapid synthesis of resorbable
polymer-clay nanocomposites for bone graft substitute applications. The process itself lends
itself to a substantial amount of control over the resulting morphology and properties of the
synthesized construct. An additional benefit to utilizing scCO2 processing is the lack of harmful
organic solvents during processing. Since lactic acid polymers are very soluble in CO2, the use
of chloroform and dichloromethane is no longer a concern.
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CHAPTER 4: STRUCTURE AND MECHANICAL PROPERTIES OF
SUPERCRITICAL CARBON DIOXIDE PROCESSED POROUS RESORBABLE
POLYMER CONSTRUCTS: INFLUENCE OF POLYMER COMPOSITION AND
PROCESSING PARAMETERS
Introduction
Currently, there are over 1 million surgical procedures performed annually in the United
States that require the use of bone graft materials. Spinal fusion, which is a surgical intervention
used to alleviate nerve root impingement and restore spinal segmental stability, accounts for
greater than 60% of bone graft material usage (www.aaos.org). In interbody (or intervertebral)
spinal fusion procedures, the gel-like nucleus pulposus is removed, the vertebral endplates are
decorticated and a bone graft material is placed in the disk space between adjacent vertebrae.
The role of the bone graft material is to facilitate bone growth and subsequent fusion between the
adjacent vertebrae, while withstanding biomechanical loading.

For this reason, the highly

porous, yet structurally stable bone harvested from the antero-superior portion of the patients’
iliac crest is considered to be the gold standard in achieving successful fusion (Samartzis et al.,
2005; Wimmer et al., 1999; Zdeblick et al., 1994).
Despite the high clinical success surrounding the use of autologous iliac crest bone in
spinal fusion procedures, the graft harvest procedure is not without risk. Donor site complication
rates as high as 33% have been reported in the literature and include an increased probability of
iliac wing fracture, tissue necrosis and infection (DePalma et al., 1972; Hu and Bohlman, 1994;
Samartzis et al., 2005; Wimmer et al., 1999). Allogenic iliac crest has been used in place of
autograft to reduce these complications, but has yet to attain comparable rates of fusion
(Samartzis et al, 2005; Wimmer et al., 1999).
Synthetic bone graft substitutes consisting of porous metals, or calcium phosphate-based
ceramics have been introduced (Sidhu et al., 2001; Zdeblick et al., 1994). While the architecture
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of these substitute materials does accurately simulate the trabecular morphology of iliac crest, the
fracture toughness of ceramic-based constructs is a concern with reports in the literature of
subsidence and loss of disk space height (Sidhu et al., 2001; Zdeblick et al., 1994). Porous
metals are also not without disadvantage as they obstruct medical imaging studies and are a
source of increased patient risk, due to device permanence (Lippman et al, 2004; Sidhu et al.,
2001; Wuisman and Smit, 2006).
Resorbable polymers, which are currently in use in orthopaedic surgery, avoid the
problems associated with permanent metallic constructs since the polymers degrade at a
predictable rate in vivo (Lippman et al., 2004; Vacaaro et al., 2004; Wuisman and Smit, 2006).
The radiolucency of the polymers also facilitates in vivo imaging without construct artifact
(Lippman et al., 2004; Vacaaro et al., 2004; Wuisman and Smit, 2006). Gradual dissolution of
the polymers in vivo also guarantees that a significant percentage of the biomechanical loading
will be transferred to de novo bone. This load transmission is essential to bone growth and
remodeling according to Wolff’s Law (Lippman et al., 2004; Samartzis et al., 2005; Sidhu et al.,
2001; Vacaaro et al., 2004; Wuisman and Smit, 2006).
Resorbable polymer devices currently in use are not suited for bone graft applications due
to the non-porous nature of their structure. Numerous techniques have been explored in tissue
engineering literature, which seek to synthesize resorbable polymer constructs with porous
structures (Georgiou et al, 2007; Hu Y et al., 2001; Kim et al., 2007; Mathieu et al., 2005; Nam
and Park, 1999; Teng et al., 2007; Wang Y et al., 2008; Zeng et al., 2003).

Phase separation

processes, which involve the dissolution of a polymer in a volatile organic solvent and
subsequent induction of a thermodynamic instability (i.e. rapid changes in temperature and/or
pressure), have been used with success (Hu Y et al., 2001; Nam and Park, 1999; Wang Y et al.,
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2008). Wang et al. recently reported success in using a collagen/PLA/hydroxyapatite composite
fabricated by a freeze-drying method in the healing of a 15 mm segmental defect in the rabbit
radius.
Despite reported pre-clinical successes, there is a biological concern regarding the
residual solvent content within the porous polymer structures. Recently, supercritical carbon
dioxide (scCO2) processing has been investigated as a biologically and environmentally friendly
alternative to creating porous, resorbable polymer structures (Georgiou et al, 2007; Kim et al.,
2007; Mathieu et al., 2005; Teng et al., 2007; Zeng et al., 2003). Several of the studies have
examined the effects of process parameters and nanoparticle incorporation on the resulting
structures. To date, no literature exists which compares the architectural, mechanical and surface
chemical properties of porous resorbable poly (lactic-co-glycolic acid) (PLGA) polymer
constructs prepared by scCO2 processing.
Synthesis of porous, resorbable polymer constructs with differing lactide-to-glycolide
ratios may aid in the development of bone grafts with tailored degradation kinetics and
mechanical properties. An understanding of the interplay between processing parameters and
polymer chemistry will lead to reproducible synthesis of polymer constructs with porous
architecture approximating that of trabecular bone. Therefore, this study seeks to evaluate the
effect of scCO2 processing parameters on the resulting architecture of porous, resorbable PLGA
constructs with different glycolic acid contents. Additionally, the effect of lactide-to-glycolide
ratio on the resulting architecture, static mechanical properties and hydrophilic surface character
will be characterized.

Materials and Methods
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Pure poly-D-lactide (100PDLA) and poly-D-lactide-co-glycolide with molar ratios of Dlactide to glycolide of 85:15 (85:15PDLGA) and 65:35 (65:35PDLGA) were purchased from
Lakeshore Biomaterials. All polymers had intrinsic viscosities in the range of 0.40-0.60 dL/g
and were terminated by ester groups.
Polymers were ground to an average particle size of 250-500 m and placed in 20 mL
borosilicate glass vials (28 mm O.D. x 61 mm H). The vials restrict radial expansion of the
polymer, but allow for expansion in the vertical direction. The polymer-filled vials, each with
2.0 g of ground polymer, were placed into a supercritical fluid reactor and saturated with CO2.
The internal pressure was elevated to 10.3, 13.8, or 27.6 MPa at an internal temperature of 35oC,
or 100oC to induce a supercritical phase transformation in the CO2. After 20 minutes of soaking,
the reactor was rapidly depressurized at a rate of 0.3-0.4 Mpa/s. To examine the effect of
confining the samples after processing, the glass vials were either broken immediately, or kept
intact for 48 hours.
Constructs were freeze-fractured with liquid nitrogen in the vertical (direction of CO2
escape) and transverse (direction perpendicular to CO2 escape) directions. Fracture surfaces
were coated with a thin film of AuPd and subjected to scanning electron microscopy (SEM,
JEOL JSM 6400, JEOL Ltd.). SEM was performed at a working distance of 15 mm and an
accelerating voltage of 20 kV.

Measurements of pore size and

pore wall thickness and

assessments of pore interconnectivity were performed using digital image analysis software
(Revolution, 4Pi Analysis). Measurements were conducted on a minimum of three vertical and
three transverse fracture surfaces. At least eight images were taken from each fracture surface.
Pore dimensions were measured for 20 pores per fracture surface image.
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Mechanical testing was performed on samples with interconnected pores ranging in
diameter from 150-250 m, which is similar to the architecture of iliac crest bone (Mosekilde
and Mosekilde, 1982; Samartzis et al., 2005).

Cylindrical cores were removed from the

specimens using a 10 mm diameter osteochondralautograft transplant system (OATS, Arthrex
Inc.). The sample areas cored were chosen to not include the dense cortical shell that was
formed at the periphery of the foams during processing. The cores were sectioned with a scalpel
to a height of 10 mm. Six samples from each co-polymer formulation were then subjected to
axial compression in a servo-hydraulic material testing machine (850 Mini-Bionix Bi-axial, MTS
Corporation). Loading took place between lubricated, stainless steel platens at a rate of 0.5
mm/min, as previously described (Georgiou et al, 2007; Mathieu et al., 2005). The samples were
compressed to a displacement equal to 50% of their original height. This displacement was
chosen because a loss of disk space height of this magnitude would represent a compromise of
neurovascular structures (Zdeblick et al., 1994). Compressive strength of the constructs was
determined by dividing the peak load by the original cross-sectional area. The compressive
modulus was quantified by calculating the slope of the elastic region of the stress-strain curve.
Elastic recovery of the samples was determined by measuring the height of the samples five
minutes after mechanical testing. The recovered height was divided by the original height and
reported as a percentage of the original height.
Water uptake experiments were performed on 10 mm x 10 mm cylinders sectioned from
the same cores used for mechanical testing.

Five cylinders from each of the polymer

formulations were initially weighed and subsequently immersed in deionized water.

The

cylinders were removed from the water and weighed at 1, 2, 4, 8, 12 and 24 hours. Prior to
weighing, the samples were placed on absorbent towels for 5 minutes and subjected to

52

compressed air (145 psi, or 1.0 Mpa). The overall change in mass was determined by dividing
the difference between the new weight and the original weight by the original weight and
multiplying by 100%. Water uptake experiements are used frequently to assess the ability to
load exogenous growth factors or autologous bone marrow aspirate into porous constructs.
Additionally, water uptake experiments provide information about the ability of cells to penetrate
a matrix. Finally, water uptake experiments are a very bulk method to determing surface
character of a materials. The surface character and hydrophilicity of implant materials have been
shown to influence osteoblast response (Baker et al., 2006; Bren et al., 2004).

Results
Effects of Processing Conditions and Polymer Composition
Processing temperature was found to influence the pore size of scCO2 processed
constructs (Figure 1, Table 1) with unconstrained radial expansion. Samples processed at 35oC
exhibited mean pore sizes of 238.0 m (+/- 4.83 m), with a few pores as large as 400 m in
diameter. Pore walls were 32.23 m (+/- 2.47 m) thick on average. In contrast, the samples
processed at 100oC had pore sizes that averaged 21.5 m (+/- 1.53 m), 17.03 m (+/- 2.33 m)
thick pore walls and a very low extent of pore interconnectivity.
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FIGURE 1. SEM images of longitudinal fracture surfaces of 65:35PDLGA samples processed
at 100oC (left) and 35oC (right) with a pressure of 13.8 Mpa and unconstrained radial
expansion.

TABLE 1. Pore diameters and pore wall thicknesses of polymeric constructs as a function of
temperature (unconstrained radial expansion).
Polymer

Average Pore Wall Diameter (mm)

Average Pore Wall Thickness (mm)

100 PDLA
35oC – 2000 psi

236.2

±4.8

32.1

±1.1

100oC – 2000 psi

22.3

±1.3

17.4

±3.5

35oC – 2000 psi

238.6

±6.5

33.0

±4.2

100oC – 2000 psi

22.1

±2.1

16.8

±1.2

35oC – 2000 psi

239.3

±3.2

31.6

±2.1

100oC – 2000 psi

20.1

±1.2

16.9

±2.3

85:15 PDLGA

65:35 PDLGA
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Construct architecture was found to be nearly identical for samples processed at 10.3,
13.8, 26.7 Mpa. Processing samples at a higher pressure did not increase the pore diameters.
Samples processed at a temperature of 100oC again showed an order of magnitude decrease in
pore size, in comparison to samples processed at 35oC, regardless of pressure.
Removal of the samples was accomplished by shattering the glass vials that contained the
sample. When samples were processed at a temperature of 35oC and were immediately removed
from the vials, a rapid increase in sample volume occurred. This volume change was not
observed upon removal after 48 hours of confinement in the glass vials. Confining the samples
for 48 hours after scCO2 processing had an effect on both average pore size and pore
interconnectivity (Figure 2). Average pore diameters decreased to 183.9 m, 216.3 m and
203.7 m for 100PDLA, 85:15PDLGA and 65:35PDLGA constructs processed at 35 oC,
respectively.

Confinement also increased the degree of interconnectivity of the constructs

processed at 35oC, as observed by SEM. Despite the fact that no method was employed to
directly quantify interconnectivity, qualitative characterization of construct architecture from
SEM images revealed that constrained samples showed more open pores and pore-pore
connections.

No changes in construct architecture due to confinement were observed for

samples processed at 100oC, again demonstrating the importance of processing temperature.
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FIGURE 2.

SEM images of longitudinal cross-sections of 85:15 PDLGA constructs

unconstrained (left) and constrained (right) after processing.

Supercritical CO2 processing of the resorbable polymers in glass vials results in the
formation of a dense outer layer on the constructs, which is rigidly attached to the porous core
(Figure 3). It should be noted that the samples used in this study underwent mechanical testing
without the dense outer layer intact.

FIGURE 3. SEM images of an iliac crest bone graft (left) and a 100PDLA construct showing
similar porous morphology and “cortical” shell.
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Mechanical Properties of Constructs
Mechanical testing of the porous polymer constructs yielded information about the
resulting static mechanical properties of the constructs. Overall, 85:15 PDLGA had the highest
compressive strength (4.35 +/- 1.78 Mpa) and compressive modulus (36.41 +/- 12.13), as shown
in Table 2. The compressive strength of 100 PDLA (3.40 +/- 0.54 Mpa) and compressive
modulus (33.79 +/- 9.3 Mpa) were lower than that of the 85:15 PDLGA, but significantly higher
than the compressive strength and modulus of 65:35 PDLGA (1.11 +/- 0.34 Mpa and 6.56 +/4.04 Mpa, respectively).

Elastic recovery was greatest for the 65:35 PDLGA constructs

(70.92%), followed by the 100 PDLA (63.84%) and 85:15 PDLGA constructs (61.89%).
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FIGURE 4.

Representative compressive stress-strain curves from each of the co-polymer

constructs, with varying PGA compositions. Samples were processed at 35oC at a pressure of
13.8 Mpa and constrained radial expansion.

TABLE 2. Static mechanical properties of porous resorbable polymer constructs synthesized by
supercritical carbon dioxide processing. Samples were processed at 35oC with a pressure of
13.8 Mpa and constrained radial expansion.
Polymer

Elastic Recovery

Compressive Strength

Compressive Modulus

(% of original height)

(Mpa)

(Mpa)

100PDLA

63.84%

±4.02%

3.40

±0.54

202.72

±55.8

85:15PDLGA

61.89%

±3.22%

4.35

±1.78

218.43

±72.76

65:35PDLGA

70.92%

±10.42%

1.11

±0.34

39.38

±24.26

Water Uptake Capacity of Constructs
All constructs demonstrated a significant weight gain within the first two hours of
immersion in deionized water (Figure 5). The weight gains tapered off significantly after the
first two hours as the polymer swelling began to approach equilibrium with the solution. The
100PDLA and 85:15PDLGA samples showed similar weight gains throughout the duration of
immersion, while the 65:35PDLGA samples exhibited a much greater weight increase at all time
points. The 65:35PDLGA samples began to show a marked decrease in mass after 12 hours of
immersion. Hydrophilicity of the polymers increases with increasing glycolic acid content,
which would enhance water uptake. As such, it was expected that the 85:15PDLGA and
65:35PDLGA samples would show larger changes in weight upon immersion. The 100PDLA
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sample does show a slightly higher weight gain than the 85:15PDLGA, but there is a significant
standard deviation in both of these sample populations.

FIGURE 5.Graph showing the change in mass of the constructs as a function of duration
immersed in deionized water.

Discussion
This study focused on the copolymer composition, mechanical behavior and
hydrophilicity of porous, resorbable polymer constructs synthesized by supercritical CO2
processing. The influence of scCO2 processing parameters on construct microstructure (i.e. pore
diameter, pore wall thickness and interconnectivity) was characterized by SEM, while
mechanical compression testing elucidated the static mechanical properties. Hydrophilicity and
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potential for growth factor loading of the porous constructs was determined by water uptake
assays.
Pore structures of the constructs were significantly influenced by the processing
temperature. This influence may be explained by the physical events that occur during scCO2
processing. When the polymer is soaked in scCO2 at elevated temperatures, significant swelling
occurs. During depressurization of the system, primary pore formation arises from the CO 2
bubble nucleation and growth. The pore structure continues to evolve as a function of CO2
escaping from the sample, which creates expansile, bi-axial flow in the polymer structure. The
combination of the low processing temperature (35˚C) and the cooling due to CO2 expansion
may reduce the sample temperature to below its glass transition during depressurization, even
with the solvation effect of any residual CO2. As the solidified sample warms up again, the
residual trapped CO2 continues to try to expand resulting in larger pores for the unconfined
construct. At 100˚C, the polymer is less viscous and the Joule-Thompson cooling due to rapid
CO2 expansion is not sufficient to reduce the temperature below the glass transition temperature
of the polymer. Therefore, all of the CO2 has escaped upon depressurization, resulting in
negligible expansion after releasing confinement.

The significant difference in pore size

between constructs processed at 35˚C and 100˚C may be attributable to a nearly fourfold
decrease in CO2 density at the higher temperature. Alternatively, process pressure was not found
to play a significant role in altering the pore structure of the resorbable polymer constructs,
possibly due to the relatively insignificant difference in the density of the CO2 at the three chosen
pressures.
Constructs synthesized by the scCO2 process exhibited a porous core and a dense outer
layer. This morphology is similar to the structure of an iliac crest bone graft, which has a thin
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cortical shell that surrounds the trabecular core (Mosekilde and Mosekilde, 1982; Samartzis et al,
2005; Sidhu et al., 2001; Zdeblick et al., 1994). The cortical shell of the iliac crest bone graft
provides structural support during biomechanical loading. It is hypothesized that the dense outer
layer of the porous, PLGA polymer constructs would provide similar structural support. The
outlayer observed on the constructs is a function of the rapid diffusion of CO2 from the surface
of the polymer construct. In the center of the construct, CO2 escape is much slower allowing for
the evolution of a porous structure. Siripurapu et al. examined methods to encourage pore
formation at the periphery of the constructs in an effort to reduce skin formation in PMMA
porous-thin film applications. Constraining the polymer limited the rapid diffusion of CO2 from
the construct surface, which encouraged the nucleation and growth of pores at the construct
surface, rather than a dense skin. Increasing depressurization rate also increased cell density in
this system.

In the present study, polymers were constrained in the radial direction and

unconstrained in the vertical direction. Lack of constraint in this direction likely facilitated rapid
CO2 escape from the surface and subsequent formation of a dense shell on the constructs. Again,
for this specific application, a dense “cortical shell” is desired to enhance load bearing capacity.
Pore interconnectivity is essential to the process of bone formation, which consists of
cellular infiltration, neovascularization and nutrient transport (DePalma et al, 1972; Samartzis et
al, 2005; Wimmer et al., 1999; Zdeblick et al., 1994). Confining the samples for 48 hours after
processing at 35oC decreased the average pore size and increased the pore interconnectivity of all
constructs, regardless of glycolic acid content. Radial expansion of the construct is limited by
the diameter of the glass vial, which results in significant internal stresses. These internal
stresses limit pore diameter and lead to pore wall collapse, which results in interconnected pores.
Immediate removal of the samples from the glass vials after processing leads to unconstrained
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expansion in the radial direction. Since there is no physical boundary to expansion, pores can
grow with less risk of wall collapse.
While the constructs showed similar architectures with the varying processing
parameters, the different polymer blends exhibited variations in static mechanical properties.
The mechanical compression testing of the constructs suggests that 85:15PDLGA and 100PDLA
samples exhibit the significantly higher compressive strength and compressive moduli (Figure 4,
Table 2) compared to the 65:35PDLGA. These have compressive strengths of 4.35 Mpa (+/1.78 Mpa) and 3.40 Mpa (+/-0.54 Mpa), respectively, which are comparable to cancellous bone
found in veretebral bodies (Jensen et al., 1990; Mosekilde and Mosekilde, 1982). The elastic
moduli of the 85:15PDLGA and 100PDLA samples, 36.41 Mpa (+/- 12.13 Mpa) and 33.79 Mpa
(+/- 9.30 Mpa) respectively, are significantly lower than the reported values of cancellous bone.
The 65:35PDLGA samples had significantly lower compressive strength and compressive
modulus of elasticity as compared to the 85:15PDLGA and 100PDLA samples. A compressive
strength of 1.11 Mpa (+/- 0.34 Mpa) and an elastic modulus of 6.56 Mpa (+/- 4.04 Mpa) suggest
that the 65:35PDLGA porous constructs may be unsuitable for orthopaedic, load-bearing
applications, such as that encountered by bone graft materials, unless a different type of construct
is considered However, these results indicate that 85:15PDLGA and 100PDLA constructs may
withstand biomechanical loads found in the cervical spine (Patwardhan et al., 2000). The
standard deviations of the compressive strength and elastic moduli values were significant, due
to regional variations in pore architecture between samples.
The recovery of sample height after the removal of the compressive load was similar for
all samples, as shown in Table 2. The 65:35PDLGA constructs showed a 70.92% (+/-10.42%)
recovery of their initial height, five minutes after the removal of the load.

This value is
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somewhat higher than the values reported for 100PDLA (63.84% +/-4.02%) and 85:15PDLGA
(61.89% +/-3.22%). This small difference may be attributed to the retention of some residual
CO2 by the 65:35PDLGA constructs.

Recovery of construct height upon removal of the

simulated biomechanical load is important in terms of maintaining disk space height (distance
between vertebrae) in the spine (Zdeblick et al., 1994).
The compressive strengths of resorbable polymer devices (dense) currently used in spine
surgery far exceed that of the porous constructs presented in this study. However, the porous
morphology of the constructs achieved by scCO2 processing offers a distinct advantage over
dense constructs, in terms of bone in-growth. Pore sizes in the range of 200-250 m are essential
for neovascularization of the graft and subsequent nutrient transport (DePalma et al., 1972;
Samartzis et al., 2005; Wimmer et al., 1999; Zdeblick et al., 1994). The dense morphology of
current resorbable polymer devices does not support the process of bone in-growth and thus must
be used in conjunction with an osteoconductive scaffold material. It is thus desireable to use the
scCO2 process to develop constructs that can simultaneously support the biomechanical loads
and provide a scaffold for bone growth.
The hydrophilic character of the polymers plays a role in the biocompatibility of the
constructs. Water uptake experiments are a bulk method for comparing surface character of
materials.

Specifically, osteoblasts have been shown to differentiate faster on hydrophilic

surfaces, rather than hydrophobic ones (Baker et al, 2006; Bren et al., 2004). Generally,
polymers that are lactic acid-based are very hydrophobic. Addition of glycolic acid to these
polymers increases the hydrophilic character of the constructs, as was evidenced by the increased
water uptake (Figure 5). Small variations in polymer chemistry, which impart a hydrophilic
character to the constructs, may be possible without sacrificing the mechanical properties of the
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construct. These water uptake experiments are also frequently used clinically to assess the
ability to load porous constructs with exogenous growth factors or autologous bone marrow
aspirate. Polymers (non-porous) currently in use in orthopaedic surgery are predominantly
comprised of lactic acid, with small amounts of glycolic acid. Further research should focus on
examining the mechanical properties of resorbable polymer constructs with molar glycolic acid
contents of less than 15%, as mechanical testing of 65:35PDLGA constructs demonstrated that
polymer blends with higher glycolic acid contents have poor structural properties. The scCO2
processing method allows for a safe, versatile solvent that enables a wide range of pore
architecture and the resultant properties.
Potential limitations of this study include the use of SEM to measure pore
interconnecitivty and pore structure. Also, the overall level of porosity was not reported for the
various constructs synthesized with different processing conditions. Intrusion porisometric, or
pyncnometric techniques are commonly employed in the quantification of pore structure,
interconnectivty and degree of porosity. While these properties were not reported, SEM was
used to ensure that the pore structure and degree of porosity were similar between all samples
that underwent mechanical testing and water uptake studies.
The fact that the compression testing was performed in a non-physiological environment
may be limitation. Hydrolytic breakdown of the biodegradable polymer has been shown to
reduce static mechanical properties, as a function of time spent in an aqueous environment. The
objective of the current study was to quantify and compare the compressive mechanical
properties at time zero, to engineer superior constructs based on pore size and processing
parameters. Experimentation is ongoing, which will seek to quantify the changes in both pore
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structure and mechanical properties as a function of duration of exposure to a simulated
physiologic environment.

Conclusions
Supercritical CO2 processing has been demonstrated to be a viable method to synthesize
porous resorbable PDLGA constructs with varying glycolic acid compositions. Further, the pore
size range (236-239 m) and degree of pore interconnectivity of the constructs synthesized by
scCO2 processing is similar to that found in iliac crest bone graft, which is considered to be the
gold standard in spinal fusion procedures.
The mechanical properties of 85:15PDLGA and 100PDLA samples indicate that these
constructs may be suitable as bone graft substitutes for use in spinal fusion procedures. Our
study indicates that, through the use of scCO2 processing, it is possible to create resorbable
constructs that possess the mechanical properties necessary to support biomechanical loads and
architectures to facilitate bone in-growth.
Incorporation of 35wt% glycolic acid improves the water uptake capacity of the
constructs by altering the hydrophilic character of the polymer. This increase in hydrophilicity
may also enhance the bone in-growth capacity of the constructs by enhancing osteoblast
response.
In summary, scCO2 processing was found to be a promising method to develop porous,
resorbable polymer constructs. The mechanical properties, porous morphology and hydrophilic
character of the resulting PDLGA constructs make them a potential candidate for bone grafting
procedures in orthopaedic surgical procedures.
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CHAPTER 5: SUPERCRITICAL CARBON DIOXIDE PROCESSED RESORBABLE
POLYMER NANOCOMPOSITES AS BONE GRAFT SUBSTITUTES
Introduction
Autogenous bone (autograft) remains a gold standard in numerous surgeries requiring
bone grafting to achieve arthrodesis and fracture union.

The inherent osteoinductivity of

autograft, coupled with its biomechanical strength make it a clear choice for the reconstruction or
replacement of load bearing structures in the body. Despite the success of surgical procedures
utilizing autograft, complication rates as high as 30% have been associated with the harvest
procedure (Malloy and Hillibrand, 2003; Samartzis et al., 2003; Wigfield and Nelson, 2001).
These complications include harvest site necrosis, significant post-operative pain and fracture at
the harvest site (Arribas-Garcia et al., 2009; Hu and Bohlman, 1994). Allogenic bone (allograft)
has been used in place of autograft with a high degree of success (Samartzis et al., 2003;
Wigfield and Nelson, 2001).

Modern donor screening and sterilization methods have

significantly reduced the rates of disease transmission, which until recently, was a significant
risk in allogenic bone graft procedures (Mally and Hilibrand, 2002; Samartzis et al., 2003). The
mechanical properties as well as the osteoinductive capacity of allograft have been shown to be
dependent on the type of sterilization employed (Malloy and Hilibrand, 2002; Chau and Mobbs,
2009). Additionally, allograft bone is in limited supply in some regions, which can limit its
applicability in major surgical procedures, such as scoliosis correction (Chau and Mobbs, 2009;
Moroni et al., 2009).
Given the limitations of autograft and allograft bone, much attention has been given to
the development of structural bone graft substitute materials. Ceramic materials, such as calcium
phosphates, have been investigated as bone graft substitutes for load bearing applications
(Wigfield and Nelson, 2001). While porous calcium phosphates such as corraline hydroxyapatite
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have high compressive strengths, the brittle nature of the material can lead to progressive
collapse of the graft resulting in poor bone healing (Chau and Mobbs, 2009). Porous metallic
constructs, such as Trabecular Metal™ (Tantalum, Zimmer Inc., WarsawIN) and Tritanium™
(commercially pure Titanium, Stryker Orthopaedics, MawahNJ) have also been introduced as
structural bone graft substitutes. The load bearing capacities of porous metal constructs are well
documented in both static and dynamic conditions. Unfortunately, long-term implantation of
non-resorbing implants is associated with an omni-present risk of infection.

Further, the

presence of a porous metallic construct may severely limit surgical options if a revision
procedure is necessary.
Due to such limitations there has been significant interest in developing resorbable
polymers, such as poly-L-lactide (PLLA) and poly-L-glycolide (PLGA), for structural bone graft
substitute applications (Chau and Mobbs, 2009; Moroni et al., 2009). To impart a porous
structure to PLLA and PLGA to enable bone growth, methods such as thermal/pressure induced
phase separation, particulate leaching and gas foaming (Baker et al., 2009; Georgiou et al., 2007;
Hu et al., 2002; Mathieu et al., 2005; Nam and Park, 1999). Phase separation techniques often
involve the use of volatile organic solvents which can be detrimental to cell growth (Nam and
Park, 1999; Teng et al., 2007). Particulate leaching must be used in combination with other
methods, such as phase separation to yield a construct with connected porosity. Gas foaming
techniques, such as supercritical carbon dioxide (scCO2), avoid the use of harmful solvents and
may not require additional methods to impart an interconnected porous structure (Baker et al.,
2009; Georgiou et al., 2007; Mathieu et al., 2005; Gualandi et al., 2010; Kanczler et al., 2010).
The mechanical properties of porous resorbable constructs synthesized by the
aforementioned means are not suitable for load bearing applications as the compressive modulus
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and compressive strengths are much lower than that of native bone. Failure of the constructs to
withstand physiologic loading conditions may result in a reduced rate of healing and in some
conditions may necessitate a revision surgical procedure. Researchers have examined reinforcing
the polymer constructs with calcium phosphates (hydroxyapatite, -TCP), phosphate glass and
carbon nanotubes (Georgiou et al., 2007; Mathieu et al., 2005; Kim et al., 2007; Khan et al.,
2008; Rezwan et al., 2006; Wang et al., 2008). The addition of these materials to polymer
matrices has resulted in modest gains in compressive strength and modulus. Calcium phosphates
and phosphate glass particles have a tendency to agglomerate within polymer mixtures, which
results in local heterogeneity that is detrimental to mechanical strength (Georgiou et al., 2007).
There is therefore a need to develop a resorbable polymer nanocomposite system and a synthesis
route which results in porous constructs with a relatively uniform dispersion of reinforcing
particles.
Recently, organically modified montmorillonite clays have been investigated as potential
reinforcing agents in polymeric matrices (Horsch et al., 2006; Manitiu et al., 2008; Pavlidou and
Papspyrides, 2008; Ray and Okamoto, 2003; Zeng et al., 2003). The clay particles are composed
of high aspect ratio silicate platelets which are approximately 100 – 500 nm in length and 1 nm
thick. These platelets are held together in stacks by van der Waals forces and the equilibrium
platelet spacing of 1 nm is generally modified by chemical techniques. One common method of
increasing platelet spacing is modification of the clay surface with alkylammonium salts.
Increasing the spacing or the dispersion of the clay platelets increases the potential for intimate
contact between polymer chains and numerous clay platelets, thus reducing polymer chain
mobility and improving mechanical properties (Horsch et al. 2006; Manitiu et al., 2008; Pavlidou
and Papspyrides, 2008; Ray and Okamoto, 2003). The processing method used to create clay-
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polymer nanocomposites also plays a role in the resulting mechanical behavior. Melt processing,
high shear mixing and post-processing heat treatments have been employed to enhance polymer
chain-clay platelet contact, with moderate property improvements (Pavlidou and Papspyrides,
2008; Ray and Okamoto, 2003). On the other hand, scCO2 processing appears to be a very
effective way to improve mechanical properties of polymer-clay nanocomposites (Horsch et al.,
2006; Manitiu et al., 2008; Zeng et al., 2003) for film and molded part applications. Diffusion of
CO2 within the clay particles and rapid depressurization leads to an increase in platelet spacing,
as well as polymer chain contact (Horsch et al., 2006; Manitiu et al., 2008). The use of scCO2
processing for dispersed biodegradable poly-d-lactide (PDLA) nanocomposites is a new concept
explored in this study.
Supercritical CO2 processing has been previously used to disperse nanoclays in
resorbable polymer matrices and to synthesize porous resorbable polymer scaffolds (Baker et al.,
2009; Zeng et al., 2003). Using scCO2 processing to synthesize nanoclay-resorbable polymer
nanocomposites may result in the production of porous scaffolds, which are suitable for
structural bone graft substitute applications.

The purpose of this study is to examine the

structure, mechanical properties and biocompatibility of porous resorbable PDLA polymer
nanocomposites synthesized by supercritical carbon-dioxide processing.

Materials and methods
MaterialsConstructs were prepared from 100% poly(D-lactic acid) (100PDLA, Lakeshore
Biomaterials, Birmingham, AL).

Nanocomposites were formed by adding nano-structured

Montmorillonite clay platelets (nano-clays). Organic modifiers based on ammonium salts are
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used to increase the intergallery spacing between silicate platelets, thus facilitating dispersion.
The nano-clay used in this study was organically modified with a methyl dehydrogenated tallow
(Cloisite 93A, Southern Clay Products, Austin, TX), as shown in Figure 1, and was used “asreceived” from the manufacturer. The size distribution of the dry particles of Cloisite 93A,
according to the manufacturer are as follows: 90% of particles are less than 13 m, 50% less
than 6 m and 10% less than 2 m.

Figure 1. Illustration of the chemical structure of the organic modifier used to increase basal
platelet spacing in Cloisite 93A nanoclay.

Construct Synthesis
Pure polymer constructs were prepared according the previously described methods
(Baker et al., 2009). Briefly, polymers were ground to an average particle size of 250-500 m
and placed in a steel tube (28 mm O.D. x 61 mm H). The tube restricts radial expansion of the
polymer, but allows for expansion in the vertical direction. The polymer-filled tube, each with
2.0 g of ground polymer, were placed into a supercritical fluid reactor and saturated with CO2.
The internal pressure was elevated to 13.8 Mpa at an internal temperature of 35oC to induce a
supercritical phase transformation in the CO2. After 60 minutes of soaking, the reactor was
rapidly depressurized at a rate of 0.3-0.4 Mpa/s.
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Synthesis of clay-polymer nanocomposite constructs was performed similarly. Nanoclay
particles were mechanically mixed with 2.0 g of ground polymer with total clay loading of
1wt%, or 2.5wt%. The steel tubes were placed into the supercritical fluid reactor and saturated
with CO2. Processing nanocomposite constructs at 35oC (similar to pure constructs), resulted in
pore sizes much smaller than those found in the pure constructs. As such, a higher temperature
was utilized for nanocomposite processing, so that both constructs would have similar pore sizes.
The internal pressure of the reactor was elevated to 13.8 Mpa and the temperature was raised to
100oC.

After 60 minutes of soaking in the supercritical CO2, the reactor was rapidly

depressurized at a rate of 0.3-0.4 Mpa/s.

The process was repeated to yield samples of

100PDLA with 1wt% Cloisite 93A (100PDLA-93A-1) and 2.5 wt% 93A (100PDLA-93A-2.5).
Constructs were freeze-fractured with liquid nitrogen in the vertical (direction of CO2
escape) and transverse (direction perpendicular to CO2 escape) directions. Fracture surfaces
were coated with a thin film of AuPd and subjected to scanning electron microscopy (SEM,
JEOL JSM 6400, JEOL Ltd.). SEM was performed at a working distance of 15 mm and an
accelerating voltage of 20 kV. Measurements of pore size, pore wall thickness and qualitative
assessments of pore interconnectivity were performed using digital image analysis software
(Revolution, 4Pi Analysis). Measurements were conducted on a minimum of three vertical and
three transverse fracture surfaces. At least eight images were analyzed from each fracture
surface. Pore dimensions were measured for 20 pores per fracture surface image.

Characterization of Nanoclay Dispersion
A RigakuSmartLabDiffractometer with a Cu Kα X-ray source (λ = 1.54 Å) and an
accelerating voltage of 40 kV at a current of 40 mA was used to determine the intergallery

74

spacing of the clay/polymer nanocomposites. Samples were placed in a custom made, zerobackground quartz sample holder that is 0.9 mm in depth and diffraction scans were collected
from 0.1 to 10º 2 at a scan rate of 3.0 degrees/min at a step size of 0.3 degrees. Several scans
were obtained from different locations in the sample and verified to be reproducible when
diffraction patterns were superimposed on one another. The 2θ angle was determined using the
JADE software that accompanies the diffractometer and the d001 spacing for the clays was
calculated using Braggs’ Law of diffraction. The intergallery spacing was then found by
subtracting 1 nm (platelet thickness) from the d001 spacing.

Rheology
A Rheometric Scientific RSA II rheometer (shear sandwich geometry 15.98 mm x 12.7
mm x 0.55 mm) was used to perform melt rheological measurements under oscillatory shear.
Rectangular slabs of samples were prepared by melt pressing the foam constructs into a mold at
80ºC between Teflon plates followed by annealing under vacuum at 80ºC to remove any residual
carbon dioxide, and also to remove the porous structure. The materials were loaded and allowed
to equilibrate for 1 hour at the desired temperature. Rheological measurements were performed
at 80ºC and 120ºC for all samples, and time-temperature superposed Data at both these
temperatures are shown with a reference temperature of 80ºC. Strain sweeps were performed to
ensure that the dynamic moduli were linear in the strain range used and the linear viscoelastic
measurements were made at low strains (γo< 0.05) to minimize microstructure destruction. The
frequency range used was 0.01 = ω = 100 rad/s and the property of time-temperature
superposition was used to create master curves with a reference temperature of 80ºC.
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Mechanical Testing
Cylindrical cores (n = 6 per testing group) with a diameter of 10 mm were obtained from
the porous PDLA constructs by using an osteochondral biopsy system. Coring the constructs
was necessary to ensure that the dense outer skin was not present during mechanical testing. The
cores were sectioned to a height of 10 mm and trimmed with a scalpel to ensure that the ends
were parallel.

The samples were placed between smooth stainless steel platens in a

servohydraulic materials testing machine (850 Mini-Bionix, MTS Inc., Eden Prairie, MN).
Constructs were loaded in compression under displacement control at a rate of 0.5 mm/min until
a strain of 50% was reached.
The compressive strength of the constructs was defined as the maximum load divided by
the initial cross sectional area. Compressive modulus was determined by calculating the slope of
the linear region of the load-displacement curve.

A one-way analysis of variance with a

Bonferroni correction and an  of 95% was used to determine the statistical significance of
mechanical data as a function of construct composition.

Osteoblast Response to Porous Nanocomposite Constructs
Human osteoblast cells (HOB, PromoCell, Heidelberg, Germany) were cultured in αmodified minimum essential medium (α-MEM, Gibco, USA; containing 2.0 mM L-glutamine
and 1 mM sodium pyruvate, without phenol red) supplemented with Osteoblast Growth Medium
SupplementMix (PromoCell; containing 10% FBS) and 1% penicillin/streptomycin (Gibco).
Cell cultures were maintained in 5% CO2 with 95% air at 37ºC until 85% confluence. Cells were
lifted using 0.05% trypsin/0.5 mM EDTA solution (PromoCell), concentrated, resuspended in
growth medium, and counted using a hemocytometer.
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Cells were seeded directly onto 10 mm diameter porous cores of 100PDLA, 100PDLA-1
and 100PDLA-2.5 nanocomposite constructs at a density of 4x104 cells per construct,with a
sample size of six per treatment group. Controls were performed using the same cell density on
polystyrene culture plates (n=6). Cultures were maintained for seven days and medium collected
and replaced every 24 hours.
Alkaline phosphatase activity was determined from cell culture supernates every 48 hours
by immunoenzymatic assay (QuantiChrom ALP Assay Kit, BioAssay Systems, Hayward, CA).
The expression of osteoprotegerin was also quantified in cell culture supernates using a beadbased immunoassay (Human Bone Panel 1B, Millipore, Billerica, MA) at the same time points.
All samples were analyzed in duplicate for a total sample size of 12 per treatment group per time
point. A one way analysis of variance (ANOVA) with Bonferroni correction was used to
compare the expression of alkaline phosphatase and osteoprotegerin by cells cultured on
polystyrene culture plates, 100PDLA, 100PDLA-1wt% and 100PDLA-2.5wt% constructs at each
time point.
Seeded nanocomposite constructs were also subjected to SEM to examine cell
morphology and mineralization. Constructs were fixed in gluteraldehyde for 24 hours and then
subjected to critical point drying. After drying, the samples were sputter-coated with AuPd and
visualized with SEM at a working distance of 8 mm and an accelerating voltage of 20 kV.
Energy dispersive X-ray spectroscopy (EDX, Link Analytical) was used to characterize the
composition of regions of suspected mineralization.

In Vitro Osteoclast Response to Nanoclay
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To investigate the degree to which bare nanoclay would stimulate an osteolytic response
in vivo, rat monocytes from bone marrow (Rat Osteoclast Precursor Cells, Kamiya Biomedical)
were cultured on disks of human dentine. Culture media consisted of alpha-minimum essential
media (-MEM) supplemented with macrophage-colony stimulating factor (M-CSF, 50 ng/mL)
and receptor activator of nuclear kappa- ligand (RANKL, 50 ng/mL). M-CSF and RANKL are
potent differentiators of macrophages and monocytes to a committed osteoclastic lineage.Cloisite
93A and Cloisite 30B nanoclays were suspended in 95% ethanol and sonicated for 15 minutes.
Cloisite 30B is another organically-modified nanoclay, and possesses a similar particle size
distribution as Cloisite 93A. Cloisite 30B is modified with methyl tallow bis-2-hydroxyethyl
quaternary ammonium, rather than methyl dehydrogenated tallow ammonium like Cloisite 93A.
Nanoclays were then dried, lyophilized and suspended in phosphate buffered saline (PBS) at a
concentration of 5.0 mg/mL. 100L of each nanoclay suspension was added to the cultured
osteoclasts, 48 hours after differentiation. 100L of sterile PBS without particles was used as a
control.
Pit formation on the dentine discs and the expression of tartrate resistant acid phosphatase
(TRAP) were used as measures of osteoclast activity. To assess pit formation, cells were lysed
from the substrate with a 2% trypsin solution.

Dentine disks were stained with Mayer’s

hematoxylin to provide depth dependent contrast changes under phase contrast microscopy.
Disks were imaged by phase contrast microscopy (Olympus IX-71, Olympus Inc.) equipped with
digital image acquisition. Pit formation was qualitatively compared between nanoclay-treated
groups and the control group after seven, 14 and 21 days in culture. TRAP staining of the
dentine disc was performed at each timepoint by first washing the dentine in PBS to remove
bound culture medium and then fixing the samples in 10% buffered formalin. The discs were
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then incubated with a solution of tartrate-containing buffer and a chromogenic substrate at 37oC
for 60 minutes. Following a wash in PBS, the discs were imaged with light microscopy.

Results
Structure and Morphology
Scaffold preparation using the supercritical CO2 method resulted in pure 100PDLA
polymer constructs with mean pore diameters of 236 m (±5 m). Similar pore diameters were
noted for PDLA-clay nanocomposite constructs (both at 1 and 2.5 wt% clay loading), as
illustrated in Figure 2, and shown in Table 1. SEM analysis of multiple fractured surfaces
showed that the pore sizes were uniform (relatively low standard deviation). No differences in
pore interconnectivity were observed as assessed by analysis of fracture surfaces by SEM.

Figure 2. Scanning electron micrographs of the porous structure of 100PDLA (left) and
100PDLA-2.5wt% (right).
Scaffolds displayed a dense skin on the outside of the constructs. This layer abruptly
transitioned to a porous interior. The morphology of the constructs was thus similar to that of
iliac crest bone grafts commonly used in spine surgery, as shown in Figure 3. The addition of
nanoclay had no observable effect on the morphology or thickness of the dense shell.
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Figure 3. Scanning electron micrographs of human corticocancellous bone harvested from the
iliac crest (left) and a 100PDLA-2.5wt% nanocomposite construct demonstrating a resemblance
of both cortical and cancellous bone structure.

Small Angle X-ray Diffraction
Diffraction spectra of the nanocomposites showed a shift in the d001 peak of pure Cloisite
93A from 3.36o to 4.41o 2, as shown in Figure 4. Using the Bragg equation it was determined
that this magnitude of shift in the 2 position corresponds to an increase in clay platelet spacing
of 1.79 nm (from 1.62 nm to 3.41 nm) after scCO2 processing. Increased platelet spacing, as
determined by X-ray diffraction has been used to determine the degree of intercalation of
organically modified clays in polymer matrices and the extent of polymer – clay interactions
present in the system (Horsch et al., 2006; Manitiu et al., 2008; Pavilidou and Papspyrides, 2008;
Ray and Okamoto, 2003). The large clay inner- gallery spacing in the nanocomposite indicates
that a large degree of dispersion and that strong interactions are present between the polymer and
the clay organic modifier. Also, the weak and broad d001 spacing in the 100PDLA/2.5wt% 93A
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sample compared to the “as received” Cloisite 93A is due to the low clay loading and a wide
distribution of clay inner-gallery spacing.

Figure 4. Small angle X-ray diffraction spectra of pure Cloisite 93A nanoclay and 100PDLA2.5wt% demonstrating a significant increase in d-spacing of the clay.

Rheology
Oscillatory shear rheology was performed on reactangular slabs of scCO2-processed
constructs after being melt pressed into a mold at 80ºC to remove all bubbles (no pores). This is
to assess the degree of clay dispersion and the extent of polymer-clay interactions (Horsch et al.,
2006; Manitiu et al., 2008; Pavilidou and Papspyrides, 2008; Ray and Okamoto, 2003). In melt
rheological studies the storage (G’) and the loss (G’’) moduli are plotted as a function of
oscillatory shear frequency, as shown in Figure 5. The frequency at which they cross (crossover
frequency) is characteristic of the matrix polymer relaxation time. Upon addition of clay, to the
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PDLA matrix, a shift in the G’/G” crossover frequency, from 0.23 to 0.10 rad/s was observed.
More importantly, an increase in the storage and loss moduli was seen upon addition of 2.5%
clay. Such observations can be attributed to a significant decrease in mobility of polymer chains
due to extensive interaction with the dispersed nano-clay (Horsch et al., 2006; Manitiu et al.,
2008; Pavilidou and Papspyrides, 2008; Ray and Okamoto, 2003), which typically improves the
mechanical properties.

Figure 5. Time-temperature superposed graphs of storage (G’) and loss (G’’) moduli of
100PDLA and 100PDLA-2.5wt%.

Mechanical Testing of Constructs
Pure PDLA constructs exhibited a compressive strength of 3.41 Mpa (±0.54 Mpa) and a
compressive modulus of 33.79 Mpa (±9.30 Mpa). The addition of 1wt% Cloisite 93a nano-clay
to the 100PDLA increased the compressive strength to 6.10 Mpa (±0.83 Mpa) and compressive
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modulus to 45.92 Mpa (±15.33 Mpa), as shown in Figure 6.

Nanocomposite constructs

containing 2.5wt% nano-clay showed an average compressive strength of 7.15 Mpa (±2.02 Mpa)
and average compressive modulus of 68.42 Mpa (±32.41 Mpa). Statistical analysis showed that
the increase in compressive strength upon addition of 1wt% of nanoclay was significant (p =
0.008) when compared to pure samples, while the change in modulus was not significant
(p=1.000).

The increase in compressive strength upon addition of 2.5wt% nanoclay was

significant when compared to pure samples (p<0.001), as was the change in modulus (p=0.040).
The increase in compressive strength from 1wt% to 2.5wt% nanoclay was not significant
(p=0.545), nor was the increase in compressive modulus (p=0.265). A post-hoc power analysis
revealed the statistical power to be 98.9% for the comparison of compressive strengths, and
49.6% for the compressive moduli.
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Figure 6.Compressive strength and compressive modulus of porous cores of 100PDLA,
100PDLA-1wt% and 100PDLA-2.5wt%.

Biocompatibility of ConstructsAlkaline phosphatase activity and expression of osteoprotegerin by human osteoblasts
cultured on the porous constructs was quantified by ELISA at days 1, 3, 5 and 7. On Day 1,
alkaline phosphatase activity was similar between controls (polystyrene culture plates) and
constructs (p=0.093), as shown in Figure 7. Expression of osteoprotegerin was higher for control
wells when compared with 100PDLA-2.5wt% constructs (p=0.007).

At Day 3, 100PDLA

constructs had the highest alkaline phosphatase activity, but the only statistically significant
difference was between 100PDLA and 100PDLA-2.5wt% constructs (p=0.013). Osteoprotegerin
expression was also highest for 100PDLA constructs at Day 3 with significant differences
between control wells, 100PDLA-1wt% and 100PDLA-2.5wt% constructs (p<0.001, p<0.001
and p<0.001, respectively). On Day 5, both control wells and 100PDLA-1wt% constructs
showed higher alkaline phosphatase activity (p=0.006 and p=0.035, respectively). 100PDLA
constructs again showed the highest expression of osteoprotegerin with significant differences
between control wells, 100PDLA-1wt% and 100PDLA-2.5wt% constructs (p=0.001, p=0.004
and p<0.001, respectively). By Day 7, the differences in alkaline phosphatase activity and
osteoprotegerin expression were again not significant (p=0.162 and p=0.135, respectively).
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Figure 7.Alkaline phosphatase activity (left) and osteoprotegerin expression (right) of human
osteoblasts cultured on 100PDLA, 100PDLA-1wt% and 100PDLA-2.5wt% compared against
polystyrene controls.

Examination of the nanocomposite scaffolds after culturing cells for 21 days revealed
copious amounts of extracellular matrix deposition (Figure 8). The deposits were comprised
mainly of calcium and phosphorus as determined by EDX. This composition is indicative of the
mineralization process. Cells and calcium phosphate deposits could be seen within pores deep in
the porous network of the constructs. The presence of cells and deposits in the center of the
constructs indicates that cells are able to infiltrate the open porous structure of the
nanocomposite constructs. Some surface degradation was noted on the outermost pore walls on
both nanocomposite formulations. This degradation manifested as irregularly shaped pores and
erosive scalloping. There were no qualitative differences noted in the degradation behavior of
the pure PDLA and PDLA-clay constructs.
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Figure 8. Scanning electron micrographs of 100PDLA-2.5wt% 93A constructs after 28 days in
culture with human osteoblasts. The top two images show a fibrous extracellular matrix
deposited by the osteoblasts, which is rich in calcium and phosphorus. The bottom image
displays some degradation of the polymer as a function of exposure to the culture media.

Nanoclay-Treated Osteoclast Pit Formation and TRAP Expression
Pit formation by osteoclasts was qualitatively assessed with phase contrast microscopy,
as shown in Figure 9. Discs from osteoclasts exposed to saline should no pit formation at seven
days. Very little pit formation was noted at the seven day timepoint on discs from osteoclasts
exposed to Cloisite 93A. Pit formation was very evident on discs from osteoclasts treated with
Cloisite 30B at day seven. Pits increased in both size and number on discs from osteoclasts
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treated with Cloisite 30B. A slight increase in the number of pits was noted for Cloisite 93A
treated osteoclasts at the 14 day timepoint. At the 21 day timepoint, pit formation was visible on
all substrates.

Figure 9. Dentine discs stained with Mayer’s hematoxylin to reveal pit formation by osteoclasts
exposed to PBS (top left), Cloisite 93A in PBS (top right) and Cloisite 30B (bottom).

TRAP staining intensity, which is correlated with resorptive activity within osteoclasts,
was assessed by light microscopy. No significant difference in the red-brown TRAP staining
was found between osteoclasts treated with saline and those treated with Cloisite 93A at any time
point. However, Cloisite 30B-treated osteoclasts elicited the most intense expression of TRAP at
each time point, as shown in Figure 10.
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Figure 10. TRAP staining of osteoclasts on dentine disks exposed to PBS (top left), Cloisite 93A
in PBS (top right) and Cloisite 30B in PBS (bottom).

Discussion
The porous morphology of the resorbable PDLA nanocomposites indicates suitability for
use as a scaffold for bone growth. Pore sizes in the range of 100-300 m have been shown to be
sufficient to support neovascularization, and cellular infiltration (Moroni et al., 2009; Khan et al.,
2008). Both pure and nanocomposite constructs synthesized for this study exhibited average
pore diameters of 236.2 m, 243.1m and 239.8 m for 100PDLA, 100PDLA-1 and 100PDLA2.5 constructs, respectively. Pore interconnectivity is also essential for the in vivo viability of
scaffolds, as it ensures the ability to transport nutrients to the center of the constructs. Though

88

no quantitative techniques were employed in this study, SEM of fracture surfaces showed that
both pure and nanocomposite scaffolds had a high degree of interconnectivity. Overall, no
significant effect of nano-clay addition was seen on the resulting morphology of the
nanocomposite constructs. Both pure and nanocomposite constructs demonstrated a dense shell,
which transitioned abruptly to a porous interior. The addition of clay had no observable effect
on the thickness or morphology of the shell, or its transition to a porous interior.

This

morphology is similar to that of the cortico-cancellous bone grafts commonly employed in
orthopaedic surgery (Malloyo and Hilibrand, 2002; Samartzis et al., 2003; Wigfield and Nelson,
2001). In these grafts, the dense cortical shell provides rigid support during biomechanical
loading.

Due to the similarity in structure, it is hypothesized that the dense shell of the

nanocomposite scaffolds would play a similar role. This hypothesis was not tested in this study,
as all mechanical testing was performed on porous cores taken from the interior of the constructs.
Small angle X-ray diffraction showed a significant increase in the 2 position of the
[001] plane of incorporated nano-clay. The shift of the peak to a lower 2 position is indicative
of an increase in the spacing of clay platelets (Horsch et al., 2006; Manitiu et al., 2008; Pavilidou
and Papspyrides, 2008; Ray and Okamoto, 2003). The basal spacing of the pure nano-clay used
in this study was found to be 2.62 nm. After scCO2 processing the clay-polymer mixtures, the
spacing increased to 4.40 nm. The measured increase in spacing is due to polymer chain
infiltration between the clay layers (Horsch et al., 2006; Manitiu et al., 2008).

During

processing, CO2 is able to diffuse in between the clay platelets as well as increase the mobility of
the polymer, which is solvated by the CO2. This facilitates polymer chain infiltration between
clay platelets and further increases platelet spacing. Upon rapid depressurization, the expansion
of CO2 within the particles forces a fraction of the clay platelets apart, significantly increasing
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the surface area available for polymer interaction. This increase in dispersion as well as the
intercalation of polymer between clay platelets results in reinforcement of the polymer matrix
and reduced mobility of the polymer chains, and can be a key factor in mechanical property
improvements (Horsch et al., 2006; Manitiu et al., 2008; Pavilidou and Papspyrides, 2008; Ray
and Okamoto, 2003).
Rheology is a commonly used tool in nanocomposite characterization for investigating
polymer-particle interaction effects, as well as particle dispersion effects. Characterization of the
rheological behavior of the pure PDLA and PDLA-clay nanocomposite constructs showed that
the nano-clay reduced the mobility of polymer chains within the construct. A shift in the
frequency at which the storage (G’) and loss (G”) moduli cross indicates a change in the socalled “characteristic relaxation time” of the polymer. In this case, a reduction in the crossover
frequency from 0.23 rad/s to 0.10 rad/s is indicative of over a doubling of the relaxation time of
the polymer. Additionally, the low frequency “terminal” region of the storage modulus has a
reduced slope when compared to the pure polymer which indicates that there is a significant
amount of clay dispersion, and improved polymer-clay interactions in the processed construct
(Ray and Okamoto, 2003). Such strong polymer clay interactions and dispersion are necessary
for the efficient transfer of stress from the matrix to the filler that is necessary to enhance
mechanic properties.
Mechanical testing of the porous constructs showed significant improvements in
compressive strength with the addition of as little as 1wt% nano-clay. Nanocomposites with 2.5
wt% nano-clay showed the highest compressive strength and compression modulus. Results
from mechanical testing show that the nanocomposite constructs compare favorably to
cancellous and cortico-cancellous human bone. Compressive strengths of the nanocomposites

90

reported in this study exceed the ranges of human cancellous bone from the mandible and lumbar
vertebral bodies as reported in literature (Giesen et al., 2001; Jensen et al., 1990; Mosekilde and
Mosekilde, 1986; Yeni and Fyhrie, 2001). Mosekilde, et al. measured the whole vertebral body
ultimate compressive strength to range from 1.5 to 7.8 Mpa (Mosekilde and Mosekilde, 1986).
The compressive strengths of thenanocomposites at 50% strain are within the range of the
ultimate compressive strength of human lumbar vertebral bodies (approximately 2.0 – 8.0 Mpa)
reported by Ebbesen, et al (Ebbesen et al., 1999). Mechanical testing data presented in this study
are for porous cores taken from the pure and nanocomposite constructs. It is hypothesized that
the dense shell that is present on the outside of the constructs will increase the resistance to
mechanical loading, thereby improving its suitability for load-bearing applications.
The mechanical properties of the nanocomposite scaffolds also compare favorably to
those reported for other synthetic polymer nanocomposite constructs (Georgiou et al., 2007;
Mathieu et al., 2005; Gualandi et al., 2010; Teng et al., 2007; Khan et al., 2008; Rezwan et al.,
2006). In a recent review article by Rezwan, et al., the reported compressive strengths for
PLGA, PLLA and PDLLA matrices filled with calcium phosphates, Bioglass or phosphate glass
fabricated using a variety of techniques range from 0.07 to 0.42 Mpa (Rezwan et al., 2006).
Mathieu, et al. have reported that utilizing a similar supercritical CO2 process a compressive
strength of up to 6.0 Mpa was achieved in PLA-TCP and PLA-HA composites (Mathieu et al.,
2005). The improvements in compressive strength and modulus observed in the polymer-clay
nanocomposites is likely due to the high reinforcement capacity of the nano-clays. The nanoclay platelets that are dispersed in the polymer matrix during scCO2 processing have a very large
aspect ratio, allowing for greater polymer-clay contact and restriction of polymer chain mobility.
The degree with which these nano-clays can be dispersed in the polymer matrix also improves
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mechanical properties, when compared to polymer constructs reinforced with calcium
phosphates. Agglomeration of calcium phosphate particles within polymer matrices has been
cited as a potential reason for the relatively modest improvements in strength (Georgiou et al.,
2007; Mathieu et al., 2005). The use of organic modifiers improves the ability of nano-clays to
be dispersed in polymer matrices (Horsch et al., 2006; Manitiu et al., 2008; Pavilidou and
Papspyrides, 2008; Ray and Okamoto, 2003).

Rapid depressurization and polymer chain

infiltration during scCO2 processing also facilitates improved dispersion of the nano-clays,
leading to improvements in mechanical behavior(Horsch et al., 2006; Manitiu et al., 2008).
Preliminary investigations of biocompatibility of the supercritical CO2-processed
resorbable polymer nanocomposite constructs suggest an overall neutral, or bioinert response by
human osteoblasts. While alkaline phosphatase activity and osteoprotegerin expression was
higher for control and 100PDLA constructs at certain time points, these differences were
insignificant after seven days in culture. Aluminosilicate materials, similar in composition and
structure to the nano-clays used in this study, have been shown to positively influence osteoblast
proliferation, differentiation and mineralization (Haroun et al., 2009; Katti et al., 2008).
However, this is the first study to examine human osteoblast response to nano-clay which is
highly dispersed in a resorbable polymer matrix by scCO2. The nano-clays used in this study are
organically-modified with alkyl-ammonium salts. However, these moieties are not likely to be
exposed to the cellular environment, as they are dispersed in the polymer matrix.. The relatively
low weight-percent of clay used in this study also minimizes the chance of organic modifierinduced cytotoxicity.

No toxic, or apoptotic response was noted within the cultures, as

evidenced by the maintenance of cell attachment and osteoblastic cell morphology.
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Ostoeblast extracellular matrix deposition on the nanocomposite constructs also indicates
favorable biological interaction. Calcium phosphate-rich deposits could clearly be seen on the
surface of the constructs, as well as within pores. This deposition was observed to also occur at
the very center of the cultured constructs, which indicates that osteoblasts are able to penetrate
the porous network of the nanocomposite constructs. Cellular infiltration of these constructs is
important for their in vivo use as bone graft substitutes. The diameter of the pores also suggests
that these constructs would also support neovascularization, which is integral for nutrient
transport. Further, the dense to porous morphology imparted by the scCO2 process closely
resembles the structure of cortico-cancellous bone grafts currently used in orthopaedic surgery.
This morphology has been shown to be important both in terms of new bone growth, as well as
in the support of biomechanical loads in vivo.
Osteoclast pit formation and TRAP expression showed a dependence on the type of
nanoclay modifier used. Exposure of cultured osteoclasts to Cloisite 30B resulted in consistently
higher concentrations of resorption pits at all time points, compared to Cloisite 93A and control
wells. Cloisite 93A also elicited the greatest expression of TRAP by the cultured osteoclasts.
Since the particle sizes of Cloisite 93A and Cloisite 30B are similar, as are their base
compositions (both Montmorillonite clays), it can be deduced that the difference in organic
modifier led to the differences observed in resorption pit formation and TRAP expression by the
osteoclasts. While differences in biologic response relative to differences in nanoclay modifier
have not been described, both Rueda and Styan have detailed the effects of Cloisite 30B clays on
cell viability and proliferation. Both in vitro studies showed a dose-dependent reduction of cell
viability and proliferation upon exposure to Cloisite 30B. While no assays were performed in
the current study to quantify viability and proliferation, the confluence of osteoclasts seemed
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similar between treatment groups and time points. Styan et al., characterized the release of
quaternary ammonium compounds (QACs) in vitro during their fibroblast study. Both Cloisite
93A and 30B contain QACs in the employed modifier. It is hypothesized that the modifier for
Cloisite 30B is either less strongly bound to the nanoclay resulting in higher in vitro
concentrations of QACs, or that the specific QAC used for Cloisite 30B is more inflammatory.

Conclusions
Supercritical CO2 processing of resorbable polymer/nano-clay mixtures results in the
formation of porous nanocomposite constructs, which exhibit biocompatibility and significant
improvements in mechanical properties. Porous resorbable polymer/nano-clay nanocomposite
constructs prepared using scCO2 processing exhibit improvements mechanical properties
comparable to human cancellous and cortico-cancellous bone (2.5 fold increase in compressive
strength compared to pure polymer constructs). Improvements in mechanical properties of the
constructs are related to the dispersion of nanoclay within the polymer matrix and subsequent
reduction in polymer chain mobility. The biocompatibility of the constructs, as determined by
alkaline phosphatase activity and expression of osteoprotegerin by cultured human osteoblasts,
was similar to polystyrene culture plate controls and resorbable polymer constructs without clay
after seven days in culture. Further in vivo studies are necessary to determine the full extent of
cellular response to polymer-clay nanocomposites, as well as construct degradation kinetics.
Supercritical CO2-processed resorbable polymer nanocomposites represent a potential alternative
to autograft and allograft in orthopaedic procedures requiring bone graft.
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CHAPTER 6: INFLUENCE OF POLYMER END FUNCTIONALITY AND NANOCLAY
ORGANIC MODIFICATION ON DISPERSION AND RHEOLOGY
Introduction
Nanocomposites composed of organically-modified Montmorillonite clay dispersed in
polymer matrices have garnered significant attention relative to significant improvements in
physical properties. Depending on the composite system, the addition of organically-modified
clay (nanoclay) can reduce gas permeability, increase flame resistance, improve thermal stability
and enhance both static and dynamic mechanical properties. As such, the applications for
polymer-nanoclay composites are as varied as the methods for synthesizing them. Owing to the
significant improvements in mechanical properties even at low concentrations of nanoclay,
polymer-clay nanocomposites have been investigated.
Recently, our group has employed supercritical carbon dioxide (scCO2) processing to
create porous resorbable polymer nanocomposites. These nanocomposites are composed of
organically modified Montmorillonite clay dispersed in a matrix of poly-D-lactide (PDLA).
Processing with scCO2 simultaneously disperses nanoclay throughout the matrix and induces an
interconnected porous morphology to the construct. Static mechanical properties of the resulting
construct constitute a two-fold change in ultimate compressive strength and significant
improvements in compressive modulus.

Rheological measurements of heat-pressed, dense

PDLA-clay nanocomposites illustrate a significant shift in the frequency of storage and loss
moduli cross-over, indicative of a large decrease in the characteristic relaxation time of the
polymer matrix. An increased slope in the terminal region of the nanocomposite, compared to
pure polymer also indicated favorable polymer clay interactions. Both of these characteristics
point towards the restriction of polymer chain mobility as the dominant mode of reinforcement
by the organically-modified Montrmorillonite clay in the PDLA matrix.
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It is recognized that enhancing the level of favorable polymer-clay interaction will result
in an overall enhancement of mechanical properties of the nanocomposite. One potential method
of enhancing polymer-clay interaction is to alter the end functionality of the polymer. Chen et al,
examined the influence of functionalizing Montmorillonite clay that had already been
organically modified with epoxy groups on dispersion within a poly-L-lactide matrix. The
addition of the epoxy end groups to the organically-modified clay led to an increase in tensile
strength, elastic modulus and elongation at failure when comparied to PLLA-clay
nanocomposites without epoxy-functionalized clay.

Epoxy functionality of the nanoclay

enhanced the degree of positive interaction with PLLA polymer chains during melt compounding
(Chen et al., 2005).
The purpose of this study is to examine the influence of polymer end functionality and
nanoclay organic modification regime on dispersion and melt-rheology of PDLA-clay
nanocomposites processed by scCO2. Interactions. Poly-D-lactide with either a lauryl ester, or
carboxylic acid end functionality were scCO2 processed with Cloisite 93A or Cloisite 30B.
Resulting constructs were characterized with small angle X-ray diffraction (SAXD) and meltrheology to determine the extent of clay dispersion within the polymer matrix, as well as the
improvements in dynamic mechanical properties.
Materials and Methods
Materials
Nanoclays used in this study remained in the as-received state from the manufacturer
(Southern Clay Products Inc., Houston, TX). Cloisite 93A, which is a Montmorillonite clay
organically modified with methyl dihydroginated tallow ammonium slat (modifier concentration
= 95 meq/100 g clay) and Cloisite 30B, which is a Montmorillonite clay organically modified
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with methyl, tallow, bis-2-hydroxyethyl quaternary ammonium salt (modifier concentration = 90
meq/100 g clay) were used to create nanocomposites. The size distribution of dry particulate of
both Cloisite 93A and Cloisite 30B particles is as follows: 10% less than 2 mm; 50% less than 6
mm and 90% less than 13 mm. Cloisite 93A has a basal d001 of 23.6 Ȧ, while the d001 for
Cloisite 30B particles was 18.5 Ȧ, per the manufacturer.

A.

B.

Figure 1. Chemical structure of the organic modifiers used in Cloisite 30B (A) and
Cloisite 93A (B), methyl tallow bis-2-hydroxyethyl quaternary ammonium and methyl
dehydrogenated tallow ammonium, respectively
Two different polymers were used as the matrix component of the nanocomposite. Both
polymers were based on pure poly-D-lactide (PDLA, SurModics Biomaterials, Birmingham, AL)
and had inherent viscosities in the range of 0.60 – 0.80 dL/g. Terminal group chemistries
differed between polymers, as one polymer was terminated by an ester group (PDLA-E) and the
other by a carboxylic acid (PDLA-A). All polymers were stored in air-tight containers until
processing at a temperature of -20oC.
Nanocomposite Synthesis
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To create PDLA-nanoclay composites, polymers were ground to an average particle size
of 100-300 m. Cloisite 30B or Cloisite 93A were mechanically mixed at ambient conditions
with either PDLA-E or PDLA-A at 2.5 wt%. This concentration has been previously shown to
result in a significant increase in compressive mechanical properties for scCO2-processed
nanocomposites composed of ester terminated PDLA and Cloisite 93A.

After mechanical

mixing, the polymer-nanoclay mixtures were placed in a steel mold within a pressure vessel.
The vessel was filled with CO2 until an internal pressure of 2000 psi was obtained, while
maintaining the temperature of the vessel at 90oC. The vessel was maintained at this pressure
and temperature for 60 minutes. After 60 minutes, the system was rapidly depressurized at a rate
of 2-4 bar/s. Following processing, the nanocomposites were stored at -20oC for 30 minutes
before removal from the molds.
Small Angle X-ray Diffraction
The intergallery spacing of nanoclay within the resorbable polymer matrices was
assessed by small angle X-ray diffraction (SAXD). Supercritcial CO2-processed nanocomposites
were sectioned into small fragments using a scalpel and palced in a custom zero-background
quartz sample holder. Using a RigakuSmartLab Diffractometer with a Cu-Kα X-ray source (λ =
1.54 Å) and an accelerating voltage of 40 kV at a current of 40 mA, scans were collected from
0.1 to 10o 2 at a rate of 3.0 deg/min with a step size of 0.30 degrees. Several scans were
obtained from different locations in the particulate sample and verified to be reproducible by
superimposing diffraction patterns. The 2θ angle corresponding to the [001] peak was
determined by analyzing the diffraction spectra with software onboard the diffractometer.
Bragg’s Law of diffraction was then used to calculated the intergallery spacing of the nanoclyas
within the polymeric matrix, subtracting 1.0 nm to account for clay platelet thickness. SAXD
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scans of pure Cloisite 30B and Cloisite 93A were also obtained in the same manner to verify the
supplier-provided d001 spacing of the nanoclays.

Rheology
To determine the impact of polymer end functionality and the method of nanoclay
organic modification on dynamic mechanical properties, melt-rheological measurements were
performed. Supercritical CO2-processed nanocomposites were heat pressed into rectangular
molds between Teflon-coated stainless steel platens at a temperature of 80oC. Samples were
than annealed in a vacuum oven at 80oC to remove residual CO2, which could negatively impact
rheology measurements.

Following adequate removal of residual CO2, melt rheological

measurements were performed under oscillatory shear using a Rheometric Scientific RSA II
rheometer. Rectangular specimens (15.98 mm x 12.7 mm x 0.55 mm) were loaded on the
machine in a shear sandwich geometry and allowed to equilibrate for one hour. Rheological
measurements were performed at 80ºC and 120ºC for all samples, and time-temperature
superposed to create master curves with a reference temperature of 80 oC. A frequency range of
0.01-100 rad/s was employed. Storage (G’) and loss (G’’) moduli were plotted against frequency
on the master curves. Melt rheological measurements of nanocomposites were compared to
those obtained for pure polymers.

Results
As-received Cloisite 30B and Cloisite 93A exhibited a d001-spacing of 1.98 nm and 2.62
nm, respectively, which corresponds to an intergallery spacing of 0.98 nm and 1.62 nm,
respectively. scCO2-processing of polymer-clay nanocomposites resulted in a shift in the 2
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peak position, as shown in Figure 2, which corresponded to an increase in intergallery spacing
for all polymer-clay combinations, as shown in Table 1.

14000
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100PDLA-93A Ester
100PDLA-93A Acid
100PDLA-30B Acid

12000

Intensity

10000
8000
6000
4000
2000
0
2

4

6

8

10

2 (deg)
Figure 2. Small angle X-ray diffraction (SAXD) of Cloisite 93A, Cloisite 30B and
nanocomposites of 100PDLA-ester or 100PDLA-acid with each of the nanoclays.

Cloisite 30B displayed the largest increases in intergallery spacing from the as-received
state with an increase of 2.15 nm with PDLA-Ester constructs and 2.55 nm with PDLA-Acid
constructs. Cloisite 93A also displayed significant increases in intergallery spacing with a 1.39
nm dilation when processed with PDLA-Ester and 1.69 nm when processed with PDLA-Acid.
Acid-terminated polymers yielded the largest increases in clay intergallery spacing in both cases.
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Table 1. Peak positions and corresponding d001-spacing of as-received Cloisite 93A, Cloisite
30B and scCO2-processed nanocomposites of PDLA and nanoclay.
Clay

Matrix

Peak Position (2)

d001-Spacing

Cloisite 93A
Closite 30B
Cloisite 93A
Cloisite 93A
Cloisite 30B
Cloisite 30B

None
None
PDLA-Ester
PDLA-Acid
PDLA-Ester
PDLA-Acid

3.36
4.46
2.20
2.61
2.13
1.95

2.62 nm
1.98 nm
4.01 nm
3.38 nm
4.13 nm
4.53 nm

Increase in
Intergallery
Spacing
--1.39 nm
1.69 nm
2.15 nm
2.55 nm

Dynamic oscillatory shear measurements demonstrate that acid-terminated PDLA
nanocomposites have lower storage (G’) and loss (G’’) moduli compared to ester-terminated
PDLA nanocomposites across a range of frequencies, as shown in Figure 3. Improvements in
both G’ and G’’ were seen for all nanocomposite constructs over pure polymers.
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Figure 3. Rheological measurements performed at 80oC and 120oC time-temperature
superposed to create a master curve of G’ and G’’ at a reference temperature of 80oC.

Both ester-terminated polymers exhibited a shift in the G’-G’’ cross-over frequency, as
shown in Figure 4. This effect was most pronounced for PDLA-Ester-93A nanocomposites and
is indicative of a reduction in characteristic relaxation time of the polymer. G’ and G’’ were
slightly increased by combining ester-terminated PDLA with Cloisite 30B, but less noticeable
after the addition of Cloisite 93A. Almost no shift in the G’-G’’ cross-over frequency was
observed for acid-terminated polymers was observed. Similarly the magnitude of G’ and G’’
were unchanged with the addition of Cloisite 93A to acid-terminated PLDA. In contrast, G’ and
G’’ increased significantly when Cloisite 30B was added to the acid-terminated PDLA.
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Figure 4. G’ and G’’ plotted against frequency for pure polymers (Top Left), PDLA-93A
nanocomposites (Top Right) and PDLA-30B nanocomposites (Bottom).

Tan (), which is the ratio of G’’ and G’, was similar between pure and
nanocomposite constructs, as shown in Figure 5. Acid-terminated polymers did show a slightly
higher value of this ratio, which is an indicator of the elasticity of the polymer melt. Esterterminated PDLA with Cloisite 93A and Cloisite 30B resulted in a reduction of Tan() indicating
a loss of elasticity upon nanoclay addition.
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Figure 5. Tan () of pure and nanocomposite materials.
Discussion
All nanocomposite constructs exhibited an increase in the intergallery spacing of
nanoclay, regardless of end functionality and nanoclay modifier.

Acid-terminated PDLA

resulted in greater increases in spacing, compared with the ester-terminated polymer. Further,
the greatest increase in intergallery spacing was seen with ester-terminated PDLA and Cloisite
30B. These results suggests that there is an effect of both polymer end functionality and
nanoclay modifier on the scCO2-mediated dispersion of nanoclay in polymer matrices. It has
been previously demonstrated that modification of nanoclay particles to improve interaction with
polymer chains leads to an improvement in dispersion. Chen, et al. grafted epoxy groups onto
nanoclay particulate and demonstrated significant improvements in dispersion in poly(L-lactide)
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(PLLA) matrices (Chen et al., 2005). Tsimpliarki, et al. also investigated the role of nanoclay
surface chemistry on dispersion within a PLLA matrix (Tsimpliarki et al., 2011). Both of these
studies focused exclusively on the modification of nanoclay, independent of its organic
modification, which increases basal plaetelet spacing. To the authors’ knowledge this is the first
study which examined the role of both polymer end functionality and chemistry of organic
modifiers in as-received organically modified Montmorillonite clays on dispersion.
Improvements in rheological behavior of the polymers were seen when Cloisite 93A or
Cloisite 30B were added. The most significant improvement observed was a shift in the G’, G’’
cross-over frequency for PDLA-Ester-93A, which is indicative of a reduction in the
characteristic relaxation time of polymer chains. A reduction in this relaxation time suggests
more solid-like behavior as a result of the restriction of polymer chain mobility by the dispersed
nanoclay (Horsch et al., 2006; Manitiu et al., 2008; Pavlidou and Papaspyrides, 2008; Ray and
Okamoto, 2002). Noticeable improvements in G’, G’’ and Tan() were observed upon the
addition of Cloisite 93A or Cloisite 30B to PDLA-Acid. As measurements were not carried out
at low frequency ranges, further characterization of rheological behavior of pure and
nanocomposite materials was not possible.

However, the improvements seen at higher

frequencies are indicative of nanoclay-dependent reinforcement of the polymer matrices. The
most significant improvements were seen for acid-terminated PDLA. It is unclear if this effect is
a function of differential interaction between the carboxylic acid end groups of the polymer and
the two different nanoclay modifiers, or if this is simply a function of the difference in initial
viscosities between PDLA-Ester and PDLA-Acid.
To further elucidate the influence of polymer end functionality and nanoclay modifier,
future rheological measurements should be performed at a lower frequency range (Maiti et al,
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2002; Ray et al., 2002; Ray et al., 2002). Considerable sample degradation was observed for
frequency ranges below 0.001 rad/s for both pure and nanocomposite samples. For lower
frequency ranges, a lower temperature should be used to minimize sample degradation. The
principle of time-temperature superposition can then be applied so that data performed at higher
frequencies (and higher temperatures) can still be analyzed simultaneously.
Conclusions
Supercritical CO2-processed PDLA-clay nanocomposites show considerable dispersion
during small angle X-ray diffraction measurements. This dispersion seems to be dependent on
both the polymer end functionality and the organic modifier of the clay. Further, dynamic
oscillatory shear measurements show improvements in rheological behavior of polymernanoclay nanocomposites. While it remains unclear if this improvement in construct rheology is
a function of polymer end group – nanoclay modifier interaction, differential improvements were
observed based on the different clays and polymers tested. We have demonstrated a method of
tailoring dispersion and dynamic mechanical properties through modification of polymer and
nanoclay surface functionality.
References
Chen G-X, Kim H-S, Shim J-H, Yoon J-S. 2005. Role of expoxy groups on clay surface in the
improvement of morphology of poly(L-lactide)/clay composites. Macromolecules 38(9), 37383744.
Horsch S, Serhatkulu G, Gulari E, Kannan RM. Supercritical CO2 dispersion of nano-clays and
clay/polymer nanocomposites. Polymer 47, 7485-7496.
Maiti P, Yamada K, Okamoto M, Ueda K, Okamoto K. 2002. New polylactide/layered silicate
nanocomposites: Role of organoclays. Chemistry of Materials 14(11), 4654-4661.
Manitiu M, Bellair RJ, Horsch S, Gulari E, Kannan RM. 2008. Supercritical carbon dioxideprocessed dispersed polystyrene-clay nanocomposites. Macromolecules 41, 8038-8046.

111

Pavlidou S, Papaspyrides CD. 2008. A review on polymer-layered silicate nanocomposites.
Progress in Polymer Science 33, 1119-1198.
Ray SS, Maiti P, Okamoto M, Yamada K, Ueda K. 2002. New polylactide/layered silicate
nanocomposites. 1. Preparation, characterization and properties. Macromolecules 35(8), 31043110.
Ray SS, Yamada K, Okamoto M, Ogami A, Ueda K. 2003. New polylactide/layered silicate
nanocomposites. 3. High-performance biodegradable materials. Chemistry of Materials 15(7),
1456-1465.
Ray SS, Okamoto M. 2003. Polymer/layered silicate nanocomposites: A review from
preparation to processing. Progress in Polymer Science 28, 1539-1641.
Tsimpliaraki A, Tsivintzelis I, Marras SI, Zuburtikudis I, Panayiotou C. 2011. The effect of
surface chemistry and nanoclay loading on the microcellular structure of porous poly(D,L lactic
acid) nanocomposites. The Journal of Supercritical Fluids 57(3), 278-287.
Zeng C, Han X, Lee LJ, Koelling KW, Tomasko DL. 2003. Polymer-clay nanocomposite foams
prepared using carbon dioxide. Advanced Materials 15(20), 1743-1747.

112

CHAPTER 7: IN VIVO INFLAMMATORY RESPONSE TO AND OSTEOINDUCTIVE
CAPACITY OF PDLA-NANOCLAY COMPOSITES PROCESSED BY
SUPERCRITICAL CARBON DIOXIDE
Introduction
Owing to the disadvantages associated with autologous and allogenic bone grafts
(autograft and allograft, respectively), there is significant interest in developing synthetic
substitute materials to enhance in vivo bone growth in clinical applications, such as fracture
healing, arthroplasty and spinal arthrodesis (Rezwan et al., 2006; Khan et al., 2008; Moroni et
al., 2009). Resorbable polymers, based on polymerized lactic- and glycolic acid are excellent
candidate materials due to their nearly four-decade history of clinical use, predictable
degradation kinetics and myriad options of processing (Rezwan et al., 2006; Khan et al., 2008).
In order to support in vivo bone formation capable of withstanding biomechanical loading, these
polymers must possess a three dimensional porous morphology. Average pore diameters in the
range of 100-300 m are necessary to support cellular infiltration and neovascularization, which
are both integral components to osteogenesis (Khan et al., 2008).
Methods such as thermal- or pressure-induced phase separation, particulate leaching and
three dimensional printing have been used to create porous constructs from resorbable polymers
(). While these methods are effective in terms of induction of an appropriate porous morphology
for bone tissue engineering, the poor static mechanical properties of the constructs preclude their
use in load bearing applications. To enhance the mechanical performance of these constructs,
researchers have attempted to reinforce the polymeric matrices with a variety of micro- and
nano-structured filler materials, including hydroxyapatite, phosphate glass and carbon nanotubes
(Rezwan et al., 2006; Khan et al., 2008; Georgiou et al., 2007; Mathieu et al. 2005). Modest
gains in compressive mechanical properties have been observed to date, which is often attributed
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to poor dispersion of the filler in the matrix, as well as poor interaction between the filler and
matrix (Georgiou et al., 2007). Supercritical carbon dioxide (scCO2) processing of organomodified nanoclays with poly-D-lactide (PDLA) polymers has shown promise in the rapid
production of porous resorbable nanocomposites for structural bone graft substitute applications
(Baker et al., 2011).

With as little as 2.5 wt% of nanoclay, the compressive mechanical

properties of the nanocomposite are nearly twice that of pure polymer scaffolds processed by
scCO2. The static compressive mechanical properties of scCO2-processed resorbable polymer
nanocomposites also compare favorably to native cortico-cancellous bone. Likewise, the porous
structure of the nanocomposite constructs mimics the dense shell-porous core morphology of
clinically-used autologous and allogenic bone graft materials, such as those harvested from the
antero-superior region of the iliac crest (Baker et al., 2009; Baker et al., 2011; Chau and Mobbs,
2009; Moroni et al., 2009).
The use of filler materials with micron and sub-micron dimensions raises a concern
regarding the potential immune and inflammatory response to the particulate debris as scaffolds
degrade in vivo. Materials used in total joint arthroplasty and spine surgery, such as cross-linked
polyethylene, poly methyl methacrylate, titanium alloy and CoCrMo alloys have been shown to
induce a potent inflammatory response when the material is reduced to a particulate state during
in vivo mechanical wear (Hallab et al., 2003; Jacobs et al., 2006). This multifactorial response
begins with engulfment of particulate debris by local macrophages (Ingham and Fisher, 2005;
Purdue et al., 2007; Holt et al., 2007). Responding macrophages express pro-inflammatory
cytokines, including tumor necrosis factor-alpha (TNF-), interleukin-1beta (IL-1), interleukin6 (IL-6), interferon-gamma (IFN-) and granulocyte/macrophage-colony stimulating factor (GMCSF) (Ingham and Fisher 2005; Purdue et al., 2007; Smith et al., 2010; Smith et al., 2010). The
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expression of these cytokines is dependent on particle characteristics, such as size, concentration,
composition and surface area (Wooley et al., 2002; Jacobs et al., 2006; Yang et al., 2002). These
cytokines are chemotactic for a number of immune cells, including monocytes. Monocytes
recruited to the site by the inflammatory cytokines differentiate into osteoclasts with active bone
resorptive capacity (Holt et al., 2007; Purdue et al., 2007). Activated osteoclasts begin to resorb
local bone, while the anabolic potential of osteoblasts and osteocytes are suppressed by cytokines
in both an autocrine and paracrine fashion (Vermes et al., 2001; Kanaji et al., 2009; Fuji et al.,
2011). The net result, if particle concentration is sufficiently high, or increasing is the creation
of cavitary defects in bone, which can compromise the stability of implants or lead to fracture
(Hallab et al., 2003; Jacobs et al., 2006). A revision procedure is often necessity following
particle-induced osteolysis in orthopaedic patients.
Particle-induced osteolysis may be an important factor to consider for resorbable polymer
nanocomposites, such as scCO2-processed PDLA-nanoclay constructs. As the nanocomposites
are comprised primarily of a polymer that will undergo hydrolytic degradation in vivo, the final
disposition of the nanoclay particles is of interest.

It is not currently known if the

nanocomposites will degrade to a final state of bare nanoclay, or if a particulate form of the
nanocomposite will arise as a function of both hydrolysis and cyclic mechanical loading. If the
nanoclay persists in “bare” form (not coated with polymer) a significant body of work suggests
that silicate-based materials possess a surface functionality conducive to mineralization.
Ishikawa, et al. profiled the morphology, alkaline phosphatase activity and markers of
mineralization in murine osteoblasts on aluminosilicate nanotubes (Ishikawa et al., 2010). The
group found an enhancement of osteoblastic differentiation, proliferation and active
mineralization (Ishikawa et al., 2010).

If the particulate remains in composite form (i.e.
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nanoclay agglomerates coated with PDLA) until complete polymeric degradation, a local
inflammatory response may develop in an effort to sequester the particles. The same theory of
particle-induced osteolysis holds for several other resorbable polymer nanocomposite systems.
Hydroxyapatite is a common filler in synthetic bone graft substitutes, due to the
osteoconductivity of bulk hydroxyapatite.

However, in vitro studies have illustrated the

inflammatory and osteolytic potential of calcium phosphate particulate (Bloebaum et al., 1998;
Sbokbar et al., 2001; Kalmodia et al., 2011).
In an effort to determine the immune and inflammatory response to resorbable polymer
nanocomposite constructs, a study has been performed to characterize the osteolytic potential of
bare particulate (filler only) and nanocomposite particulate (small particles of filler with
polymer). Hydroxyapatite has been used as a positive control, as it is a material used frequently
in bone graft substitute materials in both a clinical and pre-clinical setting. Exposure to bare
particulate is meant to represent the worst case scenario, with a completely resorbed polymer
matrix exposing the filler material to the biologic environment. A more likely scenario is
represented by the nanocomposite particulate.

Under cyclic loading, resorbable polymer

nanocomposites are hypothesized to reduce to small particles composed of both polymer and
clay. Additionally, an ectopic osteogenesis assay was performed to determine if bone formation
is influenced by the incorporation of organically-modified Montmorillonite clay in a PDLA
matrix.
Materials and Methods
In Vivo Inflammation Study
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The murine air pouch model, established by Wooley, et al. is a well-defined system for
assaying the inflammatory and osteolytic potential of the particulate form of materials used in
orthopaedic surgery (Wooley et al., 2002; Yang et al., 2002; Yang et al., 2002; Ren et al., 2006;
Ren et al., 2006). In accordance with an IACUC-approved protocol, 20 female Balb/C mice
underwent serial injections of air (1 c.c. each)on the dorsum to create a highly biologically
active, fluid-filled pouch. Air injections were performed every other day for a period of 5 days.
On day five, after confirming the integrity of the air pouch, the mice were injected with
bareparticulate (no polymer) according toTable 1.
Table 1. Treatment groups for bare particulate inflammation study.
Filler

Polymer

Sample Size

None (PBS
control)
Hydroxyapatite
Cloisite 93A
Cloisite 30B

None (PBS
control)
None
None
None

5

Concentration
(mg/mL)
N/A

5
5
5

100
100
100

A separate phase of the study was conducted to examine the inflammatory response to
nanocomposite particulate, as described in Table 2. Particulate in this format is thought to be a
more accurate representation of debris that would be generated in vivo during construct
degradation. In accordance with the same IACUC-approved protocol, 25 female Balb/C mice
underwent serial injections of air (1 c.c. each) on the dorsum for a period of 14 days. Air
injections were performed every other day for the first 7 days until the pouch remained stable
and inflated. Injections were performed every two days after that. On day 14, after confirming
the integrity of the air pouch, the mice were anesthetized with 1-2% inhaled isoflurane and the
air pouches were incised. A 1.0 cm incision provided adequate access to the pouch. Following
the incision, 100 mg of particles were implanted into the pouch. The incision was closed with 5-
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0 Prolene suture and wound adhesive (NexaBand) was applied to create a water tight closure.
After closure, the dorsum pouches were injected with 0.5 cc of saline.

Table 2.Treatment groups for polymer and nanocomposite particulate inflammation study.
Filler
None (PBS control)
None (polymer only)
Hydroxyapatite
Cloisite 93A
Cloisite 30B

Polymer
None
100 PDLA
100PDLA
100PDLA
100 PDLA

Sample Size
5
5
5
5
5

Mass of Particles
N/A
100 mg
100 mg
100 mg
100 mg

Mice were allowed ad libitum activity and free access to food and drink following the
particulate injection. 48 hours after exposure, the animals were euthanized by asphyxiation in a
CO2 chamber and subsequently underwent cervical dislocation as a means of assurance of death.
Dorsal pouch tissue was aseptically harvested with care to ensure that membranous tissue
remained intact and sectioned into two equal volume specimens.

Half of the tissue was

immersed in zinc-buffered formalin, while the remainder was snap frozen in liquid nitrogen and
subsequently stored at -80oC until analysis.
Preparation of Polymer and Nanocomposite Particles for Inflammation Study
For animals receiving an injection of bare particulate (no polymer), ultrasonication in
70% ethanol was used to remove bound endotoxin from the particles. Following 10 minutes of
sonication in 70% ethanol, the particles were transferred to 95% ethanol and left to dry in a
sterile laminar flow culture hood overnight. Particulate was then rinsed three times with sterile
PBS andresuspended in sterile PBS at a concentration of 100 mg/mL immediately prior to
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injection. Each volume was vortexed prior to injection to ensure an equal distribution of
particulate.
Polymer-coated particulate was utilized to simulate debris generated in vivo during the
hydrolytic breakdown of PDLA. Freeze fracturing and subsequent grinding of scCO2-processed
polymers and nanocomposites failed to produce a particle size conducive to implantation. As
such, a solvent casting method was used in the production of polymer and nanocomposite
particulate. The solvent casting method consisted of dissolving 2.0 g of 100PDLA in 50mL of
chloroform

under

constant

agitation.

Following

adequate

dissolution,

particulate

(hydroxyapatite, Cloisite 93A or Cloisite 30B) was stirred in until a homogenous mixture was
obtained. Hydroxyapatite was loaded into the polymer at 45wt%, while Cloisite 93A and
Cloisite 30B were loaded at 2.5wt%. The disparity in the amount of filler is reflective of the
high hydroxyapatite content used by other researchers to achieve adequate increases in
mechanical properties (Rezwan et al., 2006; Khan et al., 2008).
The mixtures were then cast in sterile Pyrex petri dishes. Mixtures were allowed to air
dry for 24 hours in a sterile laminar flow hood. Following air dyring, the mixtures were
lyophilized at a pressure of 0.045mBar for 48 hours. Particulate of a size conducive to injection
was generated from the dried mixtures by a combination of chopping with a razor and grinding
with mortar and pestle under liquid nitrogen. Particulate was suspended in 70% ethanol and
ultrasonicated for 10 minutes to remove any bound endotoxin and subsequently transferred to
absolute ethanol to drive off extra water. The particulate was again lyophilized at a pressure of
0.045 mBar for 96 hours in RN-ase and DNA-se free cryotubes in premeasured 100 mg doses.
Approximately 200 mg of each particulate mixture was kept for imaging by scanning electron
microscopy.
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Histology and Cytokine Analysis
Half of the harvested pouch tissue was dehydrated and embedded in paraffin. 5.0m
sections were created using a microtome and subsequently stained with hematoxylin and eosin
(H&E). Five H&E slides per pouch were cut for analysis. The H&E-stained sections were
analyzed under a light microscope to qualitatively assess the infiltration of the pouch tissue by
inflammatory and immune cells. Additionally, measurements of membrane thickness were made
using digital image analysis software (Scion Image, Scion Corp.).

An average of eight

measurements per slide were made.
The remainder of the pouch tissue was homogenized in a buffer solution containing a
protease inhibitor cocktail and TritonX100.

The concentration of five pro-inflammatory

cytokines including interleukin-1beta (IL-1), interleukin-6 (IL-6), granulocyte/macrophagecolony stimulating factor (GM-CSF), macrophage inflammatory protein-2 (MIP-2) and
interferon-gamma (IFN-), was quantified using a bead-based multiplex ELISA (Human Proinflammatory Cytokine Panel A, R&D Systems Inc., Minneapolis, MN). Cytokine expression
was normalized to the total protein content in each sample, as determined by a total protein
assay.
Preparation of Polymer and Nanocomposite Implants for Osteoinductivity Study
Ectopic osteogenesis assays are commonly used tools to study the ability of a scaffold to
induce or support bone formation (Ishaug-Riley et al., 1997; Jeon et al., 2007; Ji et al., 2010;
Barbieri et al., 2010). For the ectopic osteogenesis phase of the experiment, porous constructs
were synthesized using scCO2 processing, as previously described (Baker et al., 2009; Baker et
al., 2011). Pure PDLA (no clay) constructs were processed at a temperature of 35oC and a
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pressure of 2000 psi. After 60 minutes of exposure to scCO2, the reactor vessel was rapidly
depressurized to produce a porous construct. Nanocomposite constructs, comprised of PDLA
and 2.5wt% Cloisite 93A, were also synthesized with scCO2 processing.

A processing

temperature of 90oC and a pressure of 2000psi was used to generate constructs with a pore size
similar to the pure PDLA constructs. Following scCO2 processing, all materials were handled
aseptically and stored in sterile locations.
A biopsy punch was used to take porous cores from the constructs with a diameter of 6.0
mm. The cores were then sectioned into discs with a thickness of 1.0 mm. While the specimens
were handled aseptically, discs were nonethelessultrasonicated in 95% ethanol for 15 minutes to
remove any bound endotoxin. Following drying, discs were stored in a sterile laminar flow hood
until use.
Half of the pure polymer discs and half of the nanocomposite discs were selected at
random for growth factor loading. Discs were immersed in 100 L of a solution of E. Coliexpressed recombinant human bone morphogenetic protein-2 (rhBMP-2, R&D Systems Inc.,
Minneapolis, MN). The solutions were comprised of rhBMP-2 reconstituted with 4.0 mMHCl at
a protein concentration of 100 g/mL (potential for 20 g of rhBMP-2 per disc) per
manufacturer’s instructions. After 10 minutes of immersion, which is consistent with current
clinical use of rhBMP-2, the discs were removed from the solutions and air dried.
In Vivo Osteoinductivity Assay
In accordance with an IACUC-approved protocol, 36 female Balb/C mice were
anesthetized and dorsum shaved. After preparing the surgical site in a sterile fashion, an incision
was made on the dorsum of the mice over the hind limb. The gluteus muscle was identified and
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an intramuscular pouch was created using blunt dissection. Upon preparation of the gluteal
pouch, polymer or nanocomposite discs, according to Table 3, were inserted. The limb was
ranged to ensure a low likelihood of extrusion of the disc during normal gait. Wounds were
closed with suture and wound adhesive and the animals were allowed ad libitum activity upon
recovery from the anesthetic.
Table 3. Treatment groups for the in vivo osteoinductivity assay.
Group
Description
1
100PDLA
2
100PDLA + 20 g of rhBMP-2
3
100PDLA-2.5wt% 93A
4
100PDLA-2.5wt% 93A + 20 g of rhBMP-2

n
9
9
9
9

Time Points
2, 4 and 6 weeks
2, 4 and 6 weeks
2, 4 and 6 weeks
2, 4 and 6 weeks

Histology and -Computed Tomography Analysis
Mice were sacrificed at two, four and six post-operative weeks by CO2 asphyxiation and
subsequent cervical dislocation. Euthanized mice underwent CT analysis of ectopic bone
formation. A scan power of 80 kVp and a voxel size of 50 m2 was used for all animals.
Reconstructed DICOM images were analyzed by ImageJ software (National Institutes of Health,
Bethesda, MD).
Following CT imaging, the gluteal pouch and contents were aseptically harvested and
immersed in zinc-buffered formalin.

Specimens were dehydrated and embedded in paraffin.

5.0m sections were taken from the specimens and stained with H&E. Approximately five H&E
slides per animal were cut and analyzed by light microscopy.
Results
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Inflammatory Response to Bare Particulate
All animals tolerated both the air injections, as well as the particle injections. Multiplex
ELISA analysis of pro-inflammatory cytokine expression within the pouch tissue showed a
substantial increase in IL-1, IL-6 and MIP-2 for mice receiving injections of Cloisite 30B and
Cloisite 93A, compared to PBS control and hydroxyapatite particles, as shown in Figure
2.Cloisite 93A particles elicited the highest level of IL-1b (93.8 +/- 44.8 pg/mL), which was
significantly higher than both PBS controls (p = 0.009, 14.4 +/- 2.6 pg/mL) and hydroxyapatite
(p = 0.014, 18.6 +/- 7.4 pg/mL), but not significantly higher than Cloisite 30B (p=0.67, 58.9 +/47.4 pg/mL). Cloisite 93A particles also induced the highest expression of IL-6 (545.6 +/- 272.2
pg/mL), which was again significantly higher than PBS control (p<0.001, 12.1 +/- 3.6 pg/mL)
and hydroxyapatite particles (p=0.001, 11.3 +/- 4.1 pg/mL), but not significantly different than
Cloisite 30B (p=0.590, 362.4 +/- 132.6 pg/mL). GM-CSF was highest in the Cloisite 93A group
(20.7 +/- 14.7 pg/mL), followed by Cloisite 30B (17.8 +/- 14.5 pg/mL), PBS controls (0.4 +/- 0.5
pg/mL) and hydroxyapatite (0.4 +/0 0/4 pg/mL). No significant difference was found between
the groups in terms of GM-CSF expression, which may have been due to a Type II statistical
error. MIP-2 expression was again highest for the Cloisite 93A group (312.9 +/- 0.00), which
was significantly higher than all other groups (p<0.001). In contrast, IFN-g expression was
highest for PBS controls (25.8 +/- 3.2 pg/mL), which was significantly higher than Cloisite 93A
(p=0.017, 12.1 +/- 6.1 pg/mL), but not significantly different from the hydroxyapatite group
(p=1.00, 24.7 +/- 7.9 pg/mL) or the Cloisite 30B group (p=0.236, 17.2 +/- 6.4 pg/mL).
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Figure 1. Multiplex ELISA characterization of pro-inflammatory cytokine expression in air
pouch tissue injected with PBS (control), hydroxyapatite particles, Cloisite 30B or Cloisite 93A.

Analysis of histolgic sections of the mouse pouch tissue revealed a thick membranous
tissue structure within the core of specimens, as shown in Figure 2. This was likely the reactive
membrane formed both by serial injections of air, as well as injections of particulate.
Inflammatory infiltrate was observed to be more intense in animals receiving injections of
Cloisite 93A and Cloisite 30B. Cellular contents of the infiltrate tissue was predominantly
histiocytes, which is indicative of an early phase of inflammatory response. Foreign body giant
cells were identified in the tissue samples from mice receiving Cloisite 30B particulate.
Inflammatory infiltrate in tissues from mice receiving hydroxyapatite particles was minimal.
Cell contents of these tissue sections were predominantly fibroblastic, similar to the control
tissues.
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Figure 2. Histologic sections of mouse air pouches that received saline injection (top left), 100
mg/mL of hydroxyapatite particulate (top right), Cloisite 93A (bottom left) and Cloisite 30B
(bottom right) particulate.
Histologic evaluation of pouch tissues harvested after 48 hours of exposure to Cloisite
93A, Cloisite 30B, hydroxyapatite or PBS revealed significant differences in membrane
thickness, as shown in Figure 3. Tissues exposed to Cloisite 30B had the thickest membranes
(598.31 +/- 137.22 m), which was not significantly different from those exposed to
hydroxyapatite (p=1.00, 572.39 +/- 90.60 m), but was significantly higher than tissues from
PBS controls (p=0.004, 507.61 +/- 114.00 m) and Cloisite 93A (p<0.001, 470.77 +/- 115.95
m). Membrane thickness in tissues exposed to Cloisite 93A particles was significantly lower
than tissues exposed to hydroxyapatite (p<0.001), but not significantly lower than tissues
exposed to PBS (p=0.937).
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Figure 3. Histological measurements of air pouch membrane thickness from mice receiving an
injection of PBS, hydroxyapatite (calcium phosphate), Cloisite 30B and Cloisite 93A.

Inflammatory Response to Nanocomposite Particulate
Nanocomposite particulate produced by solvent casting and subsequent grinding under
liquid nitrogen results in similar sizes and morphologies between the treatment groups. All
particles possessed a prismatic morphology and apparent aspect ratio of 2:1, with a minor axis of
approximately 250 m. PDLA-HA particulate tended to have a greater degree of nanotexture,
which may be the result of the relatively high filler content. PDLA-93A and PDLA-30B
particulate, though prismatic in nature, displayed fibrillar protrusions from the main body of the
particles, as shown in Figure 4.

126

Figure 4. Scanning electron micrographs of polymer and nanocomposite particulate debris.
100PDLA (top left), 100PDLA-45wt% HA, (top right), 100PDLA-2.5wt%93A (bottom left) and
100PDLA-2.5wt%30B (bottom right).
One mouse was lost due to a pulmonary embolism immediately following one of the air
pouch injections. All other animals tolerated both the air injections and particle implantions
well, without incident. All mice that underwent an open procedure to facilitate implantation of
particulate showed measurable amounts of pro-inflammatory cytokines upon multiplex ELISA,
as shown in Figure 5. IL-6 was outside of the range of the standard curve for all tissue samples
and is not reported. MIP-2 expression was largest for PDLA-30B nanocomposite samples
(2770.0 pg/mL +/- 1304.3 pg/mL). This value was not statistically significant when compared to
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PDLA-93A (p=1.00; 2312.4 +/- 697.0 pg/mL), or PDLA-HA particulate (p=1.00; 2119.1 +/542.8 pg/mL). PDLA (no filler) particulate induced the highest expression of IFN-g (175.9 +/15.9 pg/mL).

No statistically significant differences were found with respect to IFN-g

expression between treatment groups and controls. PDLA-HA particulate yielded the greatest
expression of IL-1b (250.4 +/- 111.3 pg/mL), though there was no significant difference when
compared to PDLA (p=0.139; 111.5 +/- 76.1 pg/mL), PDLA-93A (p=1.00; 195.3 +/- 79.0
pg/mL), or PDLA-30B(p=1.00; 184.8 +/- 61.6 pg/mL). With regards to GM-CSF expression,
PDLA-HA particulate again yielded the highest expression (20.0 +/- 9.8 pg/mL) without a
significant difference found between any treatment group, or with controls.
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Figure 5. Multiplex ELISA characterization of pro-inflammatory cytokine expression in air
pouch tissue with implanted PDLA particles, PDLA-45wt% hydroxyapatite nanocomposite
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particles, PDLA-2.5wt%93A nanocomposite particles, PDLA-2.5wt% 30B nanocomposite
particles and PBS (control).

Osteoinductivity of rhBMP-2-Loaded Nanocomposites
All mice undergoing open implantation of pure PDLA and PDLA-93A discs tolerated the
procedure well and none were lost to complications.

No animals exhibited constitutional

symptoms or physical signs of infection. Upon gross observation of tissues during harvest, no
outwardly observable signs of deep infection or foreign body response were noted. Micro-CT of
the mice showed some reactive bone formation at the two week and four week time point in all
mice receiving PDLA and PDLA-93A constructs without rhBMP-2, as shown in Figure 6. This
bone formation was slightly more pronounced in the mice receiving PDLA-93A nanocomposites.
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Figure 6. Axial micro-CT images of in vivo bone growth after two weeks in mice receiving pure
PDLA constructs (Top Left) and PDLA constructs with E. Coli-expressed rhBMP-2 (Bottom
Left), compared to mice receiving PDLA-93A constructs (Top Right) and PDLA-93A constructs
with E. Coli-expressed rhBMP-2 (Bottom Right). The red ring represents the area of construct
implantation.
By six weeks, the reactive bone formation had disappeared in constructs without rhBMP2, as shown in Figure 7. Both construct types with adsorbed rhBMP-2 displayed a significant
amount of bone formation at each of the three time points. Simultaneous orthogonal projections
(combined views of axial, sagittal and coronal sections) displayed evidence of appositional, as
well as three dimensional bone growth. No differences were observed between animals which
received PDLA or PDLA-93A constructs, in terms of CT evidence of bone formation. All
animals receiving constructs with rhBMP-2 adsorbed did show more fluid accumulation in the
gluteal pouch, which is consistent with growth factor-induced bone formation.
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2 Weeks
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Figure 7. Axial micro-CT images of in vivo bone growth in PDLA-93A nanocomposites with E.
Coli-expressed rhBMP-2 (top right, bottom right) and without rhBMP-2 (top left, bottom left) at
two weeks (top row), four weeks (middle row) and six weeks post-op.
Discussion
In the simulated worst case scenario consisting of the exposure of filler materials directly
to the biologic environment, without intervening polymer chains, both Cloisite 93A and Cloisite
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30B particulate induced a significantly higher inflammatory response, compared to
hydroxyapatite and saline controls. In particular the cytokines IL-1, IL-6 and MIP-2 were
significantly elevated in the clay-treated tissues. While cytokine expression was significantly
different, no similar trends were found in measurements of membrane thickness in the pouch
tissues. This could be due to the relatively short exposure of the pouch tissue to the particulate.
Montmorillonite clay-induced inflammation is not well-described in the musculoskeletal setting.
There is a paucity of data in general regarding the immune and inflammatory response to layered
silicate structures in vivo and in vitro. Styan et al., examined the in vitro response of fibroblasts
to nanocomposites composed of polyurethane reinforced with nanoclays modified with
quaternary ammonium compounds (QAC) similar in structure to Cloisite 30B (Styan et al.,
2008). This group found a negative effect on fibroblast proliferation and viability and referred to
this effect as cytotoxicity, though no studies were performed to confirm cytotoxicity, or rule out
apoptosis and necrosis. Liquid chromatography mass spectroscopy demonstrated leeching of
QAC from the nanocomposites while in culture, which the authors posited led to the cytotoxicity
(Styan et al., 2008).

Rueda, et al., also examining polyurethane polymers reinforced with

Cloisite 30B, found a similar effect on fibroblast proliferation (Rueda et al., 2011).In contrast,
Katti, et al. found that blends of chitosan-Montrmorillonite and hydroxyapatite supported
osteoblast function with no observable reduction in viability (Katti et al., 2008).
Montmorillonite was observed to act synergistically with hydroxyapatite in supporting cell
function by the osteoblasts (Katti et al., 2008). Zhuang, et al. also did not observe a negative
effect of Montmorillonite clay in blends of gelatin and chitosan during in vitro analyses (Zhuang
et al., 2007). It should be noted that neither Katti, nor Zhuang utilized organically-modified
Montmorillonite. While Cloisite 93A is modified with a QAC, no in vitro or in vivo studies have
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been performed to date to directly assess the effect of this specific QAC on cell viability or
inflammatory response.
When the murine air pouches were challenged with nanocomposite particulate, the
differences between nanoclay-loaded and hydroxyapatite-loaded constructs were not as
substantial. MIP-2 showed the greatest difference between PDLA-HA, PDLA-93A and PDLA30B with nanoclay-loaded particulate expressing greater concentrations of the cytokine, but this
difference failed to reach statistical significance. PDLA-HA particulate actually induced a
higher expression of both IL-1 and GM-CSF, compared to PDLA-93A and PDLA-30B. IL-6
was not reported for the nanocomposites particulate challenge, as technical difficulties with this
assay were noted. Future work will include this analyte, as it has been shown to play an
important role in inflammatory response and osteoclastogenesis. These results may be attributed
both to the reduction of direct contact between nanoclay particulate and the biological
environment, as well as the difference in filler content between hydroxyapatite-loaded and
nanoclay-loaded particulate.

Clinically-used products and pre-clinical tissue engineering

constructs tend to use high concentrations of hydroxyapatite, both to enhance mechanical
properties and to potentially facilitate osteoconduction. Peng, et al. used 20 wt% hydroxyapatite
in a nanospun PLLA nanocomposite scaffold, while Guan, et al. used up to 75 wt% of
hydroxyapatite in a PLGAmatrix (Peng et al., 2011; Guan et al., 2004). For the present study,
nanocomposite particulate was loaded with 45 wt% hydroxyapatite, as this represented the
median concentration of hydroxyapatite used in recent studies. Nanoclay-PDLA particulate was
loaded with 2.5wt% Cloisite 93A or Cloisite 30B, as this was the concentration previously
shown to result in the greatest gains in compressive strength and modulus (Baker et al., 2011).
Though not a focus of this study, scCO2-processed PDLA-93A constructs exhibit compressive
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mechanical properties exceeding that of porous constructs with significantly higher
concentrations of hydroxyapatite particulate.
Though the final disposition of nanoclay in PDLA nanocomposites remains as conjecture,
a significant body of work exists detailing the mineralization of silicate structures. It is likely
that in the event of complete matrix degradation, nanoclay would be incorporated within the de
novo bone. Cunningham, et al. have demonstrated the incorporation of metallic debris within the
developing posterolateral spine fusion mass in rabbits inoculated with titanium particulate
(Cunningham et al., 2003). Further, Cunningham and colleagues demonstrated no significant
reduction in bone formation as a function of exposure to the particulate, despite significantly
elevated pro-inflammatory cytokine production and osteoclast activity (Cunningham et al.,
2003). Nanocomposites synthesized for this study are not intended to be used in bearing surface
applications, such as total joint arthroplasty devices. As such, the final size and morphology of
particles will vary significantly with the particle sizes and morphologies used in in vitro and in
vivo studies examining the osteolytic potential of mechanical wear debris. No data currently
exists, which has examined the physical characteristics of particulate shed from porous
resorbable polymer nanocomposites as a function of cyclic loading in an aqueous media. Future
research will focus on creating nanocomposites particulate that more closely resembles the
physical characteristics of debris found in vivo.
PDLA and PDLA-93A constructs synthesized by scCO2 processing showed the ability to
support in vivo bone formation, when functionalized with E. Coli-expressed rhBMP-2. Similar
to other studies, the constructs displayed both appositional bone growth, as well as three
dimensional infiltration of osteogenesis. These results suggest that the interconnected, porous
morphology of the constructs are sufficient for bone graft applications where three-dimensional
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bone growth is desired and often achieved with the addition of exogenous growth factors. No
significant difference was noted between PDLA and PDLA-93A constructs in terms of bone
growth at early time points. This results suggests that, despite the increased inflammatory
response to nanoclay when compared with hydroxyapatite at identical concentrations, bone
growth remains unaffected.

Future studies will also seek to characterize neoangiogenesis

associated with bone growth on the nanocomposites constructs. Vessel formation is an important
requirement for the growth of sustainable osseous tissue. Results from the four week and six
week timepoints, are encouraging, as bone resorption is a hallmark of non-viable and nonnutrient supplied neo-osseous tissue.
Conclusions
This is the first study to demonstrate the in vivo inflammatory response to Cloisite 30B,
Cloisite 93A and nanocomposite particulate composed of these nanoclays dispersed in a PDLA
matrix. The inflammatory response to PDLA-93A and PDLA-30B nanocomposite particulate
was substantially equivalent to the more traditional PDLA-HA compositions, suggesting
appropriate biocompatibility. Additionally, this study demonstrated the ability of supercritical
carbon dioxide-processed PDLA-93A nanocomposites to support exogenous growth factorinduced bone formation. Supercritical CO2-processed resorbable polymer-clay nanocomposites
may be suitable as bone graft substitute in load-bearing orthopaedic applications.
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Numerous clinical situations necessitate the use of bone graft materials to enhance bone
formation. While autologous and allogenic materials are considered the gold standards in the
setting of fracture healing and spine fusion, their disadvantages, which include donor site
morbidity and finite supply have stimulated research and development of novel bone graft
substitute materials. Among the most promising candidate materials are resorbable polymers,
composed of lactic and/or glycolic acid. While the characteristics of these materials, such as
predictable degradation kinetics and biocompatibility, make them an excellent choice for bone
graft substitute applications, they lack mechanical strength when synthesized with the requisite
porous morphology.

As such, porous resorbable polymers are often reinforced with filler

materials. In the presented work, we describe the use of supercritical carbon dioxide (scCO2)
processing to create porous resorbable polymeric constructs reinforced by nanostructured,
organically modified Montmorillonite clay (nanoclay).

scCO2 processing simultaneously

disperses the nanoclay throughout the polymeric matrix, while imparting a porous morphology to
the construct conducive to facilitating cellular infiltration and neoangiogenesis, which are
necessary components of bone growth. With the addition of as little as 2.5wt% of nanoclay, the
compressive strength of the constructs nearly doubles putting them on par with human cortico-
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cancellous bone. Rheological measurements indicate that the dominant mode of reinforcement
of the nanocomposite constructs is the restriction of polymer chain mobility. This restriction is a
function of the positive interaction between polymer chains and the nanoclay.

In vivo

inflammation studies indicate biocompatibility of the constructs. Ectopic osteogenesis assays
have determined that the scCO2-processed nanocomposites are capable of supporting growthfactor induced bone formation. scCO2-processed resorbable polymer nanocomposites composed
of resorbable polymers and nanocaly exhibit physical, mechanical and biologic properties that
make them excellent candidate materials for structural bone graft substitute applications.
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